BEGIN:VCALENDAR VERSION:2.0 PRODID:-//SciLifeLab - ECPv6.17.4.1//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:SciLifeLab X-ORIGINAL-URL:https://www.scilifelab.se X-WR-CALDESC:Events for SciLifeLab REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:Europe/Stockholm BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20250330T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20251026T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20260329T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20261025T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20270328T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20271031T010000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20260908T110000 DTEND;TZID=Europe/Stockholm:20260908T120000 DTSTAMP:20260820T133310Z CREATED:20260819T112645Z LAST-MODIFIED:20260820T133310Z UID:10001862-1788865200-1788868800@www.scilifelab.se SUMMARY:Webinar on Calls for New Projects in Chemical Biology and Drug Discovery DESCRIPTION:The Chemical Biology Consortium Sweden (CBCS) and the Drug Discovery and Development (DDD) Platform at SciLifeLab invite researchers to submit proposals for new collaborative projects.Chemical biology projectsThe Chemical Biology unit (CBCS) welcomes projects involving: \n\n\n\n\nAssay development for small-molecule screening\n\n\n\nPhenotypic and target-based screening and in silico – virtual screening support\n\n\n\nEnabling chemistry\, including medicinal and computational chemistry\n\n\n\nDrug profiling projects in advanced cell models (patient derived material and 3D cultures)\n\n\n\n\nMany of the projects supported by CBCS involve phenotypic screening addressing basic research\, disease biology but also projects outside human health. Further information is available at www.cbcs.se.Drug discovery & Development projectsThe DDD Platform invites proposals addressing a clearly defined unmet medical need and offering a credible route toward commercialisation. Projects involving any therapeutic modality that can be developed in collaboration with DDD are welcome\, including: \n\n\n\n\nSmall molecules\n\n\n\nAntibodies\n\n\n\nOligonucleotides\n\n\n\nEmerging therapeutic modalities\n\n\n\n\nThis year’s call introduces a joint opportunity supported by CBCS\, DDD and MAX IV. \n\n\n\nNew opportunity: Enabling Drug Discovery (EDD)Through the Enabling Drug Discovery (EDD) initiative\, the combined capabilities of SciLifeLab DDD\, CBCS and MAX IV offer academic researchers an integrated workflow for early-stage target based drug discovery. The support includes expert support on assay design\, technology transfer and hit verification\, together with access to complementary discovery approaches such as: \n\n\n\n\nAI-assisted in silico screening for small molecules\n\n\n\nHigh-throughput screening (HTS) for small molecules\n\n\n\nSelection for small molecule binders from DNA-encoded compound libraries (DEL)\n\n\n\nFragment screening (crystallographic screening at MAX IV and by NMR at CBCS)\n\n\n\nSelection for human antibody fragments from Phage display libraries\n\n\n\nDesign and synthesis of custom-made oligonucleotide libraries\n\n\n\n\nPrincipal investigators who successfully co-develop and validate suitable assays will be offered the opportunity to screen for potential therapeutic candidates. The resulting hits and data can provide a strong foundation for further scientific investigation and subsequent applications to SciLifeLab’s CBCS and Drug Discovery and Development (DDD) platforms.Some users and projects are at the intersection between chemical biology and drug discovery.This webinar aims to guide users to the call that best suits the needs of their project. \n\n\n\nRegister URL:https://www.scilifelab.se/event/calls-for-new-projects-in-chemical-biology-and-drug-discovery/ CATEGORIES:Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20260909T090000 DTEND;TZID=Europe/Stockholm:20260910T133000 DTSTAMP:20260907T092435Z CREATED:20260513T143630Z LAST-MODIFIED:20260907T092435Z UID:10001825-1788944400-1789047000@www.scilifelab.se SUMMARY:PLP Network Meeting 2026 DESCRIPTION:The Pandemic Laboratory Preparedness (PLP) Network Meeting brings our community together to strengthen connections across the PLP network\, spark new collaborations\, and identify exciting opportunities for future development and impact. \n\n\n\nThrough inspiring invited talks\, an engaging poster session\, interactive group discussions\, and plenty of social activities\, the meeting will create a dynamic forum for exchanging ideas\, sharing expertise\, and building the partnerships that will shape future pandemic preparedness efforts \n\n\n\nInvitation only \n\n\n\nContact. Alice Sollazzo\, alice.sollazzo@scilifelab.uu.se \n\n\n\n\n\n\n\nProgram\n\n\n\nProgram PLP Network Meeting 2026Download\n\n\n\nPoster List\n\n\n\nPoster List – PLP Retreat 2026Download\n\n\n\nBusses\n\n\n\nTo Nova Park – September 9FromDepartureUppsala (BMC)\, Husargatan 3\, entrance C1109:00Stockholm\, Cityterminalen (via Campus Solna)08:30Arlanda\, T409:00From Nova Park – September 10DepartureToUppsala (BMC)\, Husargatan 3\, entrance C1113:30Stockholm\, Cityterminalen (via Campus Solna)13:30Arlanda\, T413:30\n\n\n\n\n\n\n\nScientific Committee:\n\n\n\n\nStaffan Svärd\, UU\n\n\n\nJessica Alm\, KI\n\n\n\nClaudia Fredolini\, KTH\n\n\n\nTobias Allander\, KI\n\n\n\nMattias Forsell\, UmU\n\n\n\nMahmoud Naguib\, UU URL:https://www.scilifelab.se/event/plp-network-meeting-2026/ LOCATION:Nova Park\, Gredelbyvägen 138\, 741 71\, Knivsta CATEGORIES:Event ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20260909T150000 DTEND;TZID=Europe/Stockholm:20260909T160000 DTSTAMP:20260825T110844Z CREATED:20260626T081628Z LAST-MODIFIED:20260825T110844Z UID:10001849-1788966000-1788969600@www.scilifelab.se SUMMARY:Improving Science with Science: Open Research\, Equity\, and Contributor Recognition DESCRIPTION:SciLifeLab CoARA working group invites you to the first in a series of webinars during the autumn 2026. We welcome  Dr Malgorzata Lagisz\, School of Biological SciencesUniversity of Alberta\, Canada presenting “Improving Science with Science: Open Research\, Equity\, and Contributor Recognition” on Sept 9th. \n\n\n\nWhen: Sept 9\, at 15-16 CEST on Zoom \n\n\n\n\nRegister\n\n\n\n\nAbstract \n\n\n\nScience faces growing challenges related to reproducibility\, transparency\, equity\, and trust. In this seminar\, I will discuss how Open Science practices and meta-research can work together to improve the reliability and inclusivity of scientific research. Dr Lagisz will introduce key ideas behind the Open Science movement and present examples of meta-research projects from the group and global collaborations investigating research culture\, contributor recognition\, and equity in science. These include large-scale analyses of authorship and acknowledgment practices\, revealing that many important scientific contributions remain poorly recognised and invisible in scholarly databases. Together\, these projects demonstrate how empirical research on science itself can help identify structural barriers and inform practical reforms to improve transparency\, collaboration\, and fairness in research systems. Dr Lagisz will conclude by sharing resources and tools for contributing to a more open\, trustworthy\, and collaborative scientific enterprise. \n\n\n\n \n\n\n\nShort bio: Dr Malgorzata (“Losia”) Lagisz is an Associate Professor at the University of Alberta. With prior appointments in UK\, New Zealand\, and Australia\, her interdisciplinary research spans ecology\, evolutionary biology\, biomedical science\, environmental studies\, and social science. She uses evidence synthesis (systematic reviews\, meta‑analyses\, systematic maps\, and meta‑epidemiology) to tackle critical questions across disciplines. Dr Lagisz co‑leads a team dedicated to advancing evidence synthesis\, Open Science and equity in research. Learn more mlagisz.weebly.com. \n\n\n\nFor questions contact the SciLifeLab CoARA working group via datacentre@scilifelab.se \n\n\n\nSciLifeLab joined the Coalition for Advancing Research Assessment (CoARA) as a member and signatory in 2024\, committing to contribute to improve research assessment practices both on a national\, and international level. The SciLifeLab CoARA Working Group formed in the Spring of 2024 and consist of both SciLifeLab representatives and representatives from the host universitites. Additionally\, SciLifeLab is part of the Swedish National Chapter of CoARA\, strengthening the commitment to improving research assessment in Sweden. Learn more about the SciLifeLab CoARA working group in this news item URL:https://www.scilifelab.se/event/improving-science-with-science-open-research-equity-and-contributor-recognition/ ORGANIZER;CN="SciLifeLab Data Centre":MAILTO:datacentre@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20260910T120000 DTEND;TZID=Europe/Stockholm:20260910T130000 DTSTAMP:20260914T094154Z CREATED:20260819T115550Z LAST-MODIFIED:20260914T094154Z UID:10001863-1789041600-1789045200@www.scilifelab.se SUMMARY:Campus Solna Seminar Series: Jakub Mlost & Pranauti Panshikar DESCRIPTION:Welcome to join the Campus Solna Seminar Series – an initiative to promote the fantastic science ongoing at Campus Solna and hopefully forge more internal communication and collaboration between within Campus Solna. The format consists of two 20 min talks (One speaker from the Alpha-building and one from the Gamma-building respectively)\, with an additional 5 min of questions. Presentation of ongoing (unpublished) projects is strongly encouraged. \n\n\n\nThe seminars are held Thursdays 12:00-13:00. You can bring your lunch to the seminar. \n\n\n\nPhD students that are attending the Campus Solna Seminar lectures will have the opportunity to gain credits. For the syllabus and instructions on how to obtain these credits\, read this document. Please contact your own department at your host University to confirm.See here the full schedule for this semester. \n\n\n\nThis week:\n\n\n\n\n\n\nJakub Mlost\n\n\n\nIskra Pollak – gamma 5 \n\n\n\nBridging Genes\, Drugs\, and Behavior: Multiscale Effects of Psilocybin in C57BL/6 Mice \n\n\n\n\n\nPranauti Panshikar\n\n\n\nSpatial Proteomics – alpha 2 \n\n\n\nDevelopment and implementation of multi-omics methods in translational and clinical research​ \n\n\n\n\n\n\nThis seminar series is organized by the PhD & Postdoc Council. For more information about the Council and other events check our page. URL:https://www.scilifelab.se/event/campus-solna-seminar-series-10sept/ LOCATION:Milkyway SciLifeLab Solna\, Tomtebodavägen 23\, Solna CATEGORIES:Community ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2022/09/IMG_20221103_124630107_HDR-scaled.jpg ORGANIZER;CN="SciLifeLab Solna PhD & Postdoc Council":MAILTO:phd-council@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20260910T143000 DTEND;TZID=Europe/Stockholm:20260910T150000 DTSTAMP:20260825T080219Z CREATED:20260825T080218Z LAST-MODIFIED:20260825T080219Z UID:10001879-1789050600-1789052400@www.scilifelab.se SUMMARY:Sleeping sickness on the path to disease elimination: The tale of two drugs DESCRIPTION:Welcome to a seminar with Peter Sjö in the Chemical Biology Seminar Series. \n\n\n\nPeter Sjö\, Head Drug Discovery Projects at Drugs for Neglected Diseases initiative (DNDi). URL:https://www.scilifelab.se/event/sleeping-sickness-on-the-path-to-disease-elimination-the-tale-of-two-drugs/ LOCATION:Gamma 2 Lunchroom\, SciLifeLab\, Tomtebodavägen 23\, Solna\, Sweden CATEGORIES:Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20260916T091500 DTEND;TZID=Europe/Stockholm:20260916T103000 DTSTAMP:20260914T080814Z CREATED:20260908T120519Z LAST-MODIFIED:20260914T080814Z UID:10001890-1789550100-1789554600@www.scilifelab.se SUMMARY:Molecule-scale resolution and dynamics in fluorescence microscopy DESCRIPTION:Guest Lecture by: Prof. Dr. Stefan W. HellDirector\, Max Planck Institute for Multidisciplinary Sciences\, GöttingenDirector\, Max Planck Institute for Medical Research\, HeidelbergNobel Laureate in Chemistry (2014) \n\n\n\n \n\n\n\nHost: Jan Ellenberg\, SciLifeLab Director \n\n\n\nSpace is limited\, please sign up to secure your seat. Venue: ”Air&Fire”\, SciLifeLab Campus Solna\, Tomtebodavägen 23A. [Or live streamed via Zoom – sign up to receive link] \n\n\n\nRegistration\n\n\n\nBiography\n\n\n\n \n\n\n\nStefan Hell is a director at both the Max Planck Institute for Multidisciplinary Sciences in Göttingen and the Max Planck Institute for Medical Research in Heidelberg\, Germany. \n\n\n\nHe is credited with having conceived\, validated and applied the first viable concept for overcoming Abbe’s diffraction-limited resolution barrier in a light-focusing fluorescence microscope. For this accomplishment he has received numerous awards\, including the 2014 Kavli Prize in Nanoscience and the Nobel Prize in Chemistry. \n\n\n\nStefan Hell received his doctorate (1990) in physics from the University of Heidelberg. From 1991 to 1993 he worked at the European Molecular Biology Laboratory\, followed by stays as a senior researcher at the University of Turku\, Finland\, between 1993 and 1996\, and as a visiting scientist at the University of Oxford\, England\, in 1994. In 1997 he was appointed to the MPI for Biophysical Chemistry (named Max Planck Institute for Multidisciplinary Sciences since 2022) in Göttingen as a group leader\, and was promoted to director in 2002. From 2003 to 2017 he also led a research group at the German Cancer Research Center (DKFZ). Hell holds honorary professorships in physics at the Universities of Heidelberg and Göttingen. \n\n\n\nCopyright: MPImR URL:https://www.scilifelab.se/event/molecular-scale-resolution-and-dynamics-in-fluorescence-microscopy/ LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden CATEGORIES:Event ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20260916T150000 DTEND;TZID=Europe/Stockholm:20260916T160000 DTSTAMP:20260806T141715Z CREATED:20260806T141714Z LAST-MODIFIED:20260806T141715Z UID:10001853-1789570800-1789574400@www.scilifelab.se SUMMARY:Synthetic DNA for in-product data storage and cryptography DESCRIPTION:Robert Grass\, Functional Materials Laboratory\, Department of Chemistry and Applied Biosciences\, ETH Zurich \n\n\n\nShort abstract:DNA data storage has emerged as technical solution to store digital data at very high data densities. In addition\, data in DNA can be rendered stable for long time horizons by the application of nanotechnological preservation technologies\, using both sol-gel as well as metal organic framework approaches. In practical terms\, DNA data storage offers data stability for hundreds of years and data densities exceeding 40 exabytes per gram. While this brings opportunities in the field of cloud storage applications\, our research focuses more on ideas in combining DNA data storage with materials. It is our ultimate goal to give materials a digital identity. We have so far investigated applications in 3d printing\, pharmaceuticals\, construction materials and polymer recycling. I will not only be discussing the technical advantages and limitations\, but will also touch on practicability and technology commercialisation aspects. I will conclude the presentation on a second class of lesser-known digital technologies\, which uses physical and chemical randomness to create unclonable functions\, and allows a discussion of physical randomness in the context of digital cryptography. URL:https://www.scilifelab.se/event/synthetic-dna-for-in-product-data-storage-and-cryptography/ LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden CATEGORIES:Event ORGANIZER;CN="Ian Hoffecker":MAILTO:ian.hoffecker@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20260917T084500 DTEND;TZID=Europe/Stockholm:20260917T170000 DTSTAMP:20260916T111826Z CREATED:20260615T092942Z LAST-MODIFIED:20260916T111826Z UID:10001847-1789634700-1789664400@www.scilifelab.se SUMMARY:Campus Solna Science Talks 2026 DESCRIPTION:Warmly welcome to the seventh Campus Solna Science Talk – a meeting for everyone in the community to learn more about ongoing research and activities at SciLifeLab’s Campus Solna\, which aims to bring the community together\, inspire exchange and new collaborations. \n\n\n\nResearch presentations will be given by group leaders and junior researchers (selected with consideration for balance in topics\, presenters’ career stages\, and affiliations) as part of four plenary sessions that will be mixed with panel discussions. During breaks and lunch there will be ample time for networking and poster sessions. \n\n\n\nWe invite all Campus Solna research groups to be represented with at least 1 poster (and maximum 3). Furthermore\, we want to encourage all infrastructure units\, support functions (IT\, OO\, Site support) and committees (DEI\, Public Engagement\, CSI and the PhD&Postdoc Council) to partake with posters! \n\n\n\nSeats are limited\, register today to secure your spot! \n\n\n\nRegistration\n\n\n\n \n\n\n\nProgram\n\n\n\nProgram CS Science Talks 2026Download\n\n\n\nPoster list\nPoster session A and B names and titles (1)_v2Download\n\n\n\n\nScientific committee\nHjalmar Brismar \n\n\n\nErik Benson \n\n\n\nMagda Bienko \n\n\n\nAnniina Vihervaara \n\n\n\nPatrick Bryant \n\n\n\nGisele Miranda \n\n\n\nAbishek Arora \n\n\n\nBruno Stojcic \n\n\n\nDisa Larsson Hammarlöf\, OO-support \n\n\n\nIsolde Palombo\, OO-support URL:https://www.scilifelab.se/event/campus-solna-science-talks-2026/ LOCATION:Life City\, Solnavägen 3H\, Stockholm\, 113 64 CATEGORIES:Event ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2022/09/Fasad-SciLifeLab-Solna-2022-2-1-scaled.jpeg ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20260918T100000 DTEND;TZID=Europe/Stockholm:20260918T110000 DTSTAMP:20260910T110908Z CREATED:20260910T085914Z LAST-MODIFIED:20260910T110908Z UID:10001892-1789725600-1789729200@www.scilifelab.se SUMMARY:AI for analysis of microscopy data - powers and pitfalls DESCRIPTION:Carolina Wählby \n\n\n\nNBIS and SciLifeLab Data Centre arrange an open SciLifeLab AI Seminar Series aimed at knowledge-sharing about Artificial Intelligence and applications in the Life Science community. The seminar series is open to everyone. The seminar is run over Zoom on the third Friday of the month during academic terms\, typically between 10 and 11 am\, with approx. 45 min presentation and 15 min discussion. \n\n\n\nWhen: September 18\, 10:00-11:00 \n\n\n\nWhere: Zoom http://meet.nbis.se/ainw \n\n\n\nSpeaker: Carolina WählbyProfessor of Quantitative Microscopy\, SciLifeLab and Dept. IT\, Uppsala University \n\n\n\nAbstract \n\n\n\nWe see every day improvements in the abilities of AI models to extract information\, answer questions\, and produce human-comprehensible summaries of large amounts of data.But how do we ensure scientific rigor\, and how do we know if we can trust the results?My research is focused on digital image processing and analysis\, primarily for applications in life science\, at the microscopy scale. This ranges from efficient approaches to decoding in spatial transcriptomics data to detecting signs of malignancies in digital pathology data. I will talk about the developments in the field\, the powers and the pitfalls of the new technologies\, and the strategies I believe in when striving to maintain a scientific approach\, rather than simply leaning back expecting the AI to do the science for us. Many of the examples will also come from the work done within the SciLifeLab BioImage Informatics Unit of NBIS (BIIF). \n\n\n\n \n\n\n\nTo stay updated\, you can join our email list by contacting ai-network@scilifelab.se. \n\n\n\n\nJoin Seminar URL:https://www.scilifelab.se/event/ai-for-analysis-of-microscopy-data-powers-and-pitfalls/ LOCATION:Online event via Zoom CATEGORIES:Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20260918T110000 DTEND;TZID=Europe/Stockholm:20260918T120000 DTSTAMP:20260909T085452Z CREATED:20260908T083144Z LAST-MODIFIED:20260909T085452Z UID:10001881-1789729200-1789732800@www.scilifelab.se SUMMARY:Drug Discovery Seminar: Hit Finding Approaches in a Pharmaceutical Industry Setting - with focus on small molecules\, degraders and oligos DESCRIPTION:Registration URL:https://www.scilifelab.se/event/drug-discovery-seminar-hit-finding-approaches-in-a-pharmaceutical-industry-setting-with-focus-on-small-molecules-degraders-and-oligos/ LOCATION:Online event via Zoom CATEGORIES:Event ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2026/09/AdobeStock_2125323275-scaled.jpeg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20260921T100000 DTEND;TZID=Europe/Stockholm:20260921T170000 DTSTAMP:20260910T131307Z CREATED:20260511T122837Z LAST-MODIFIED:20260910T131307Z UID:10001817-1789984800-1790010000@www.scilifelab.se SUMMARY:Research Data Management in Life Science - Linköping DESCRIPTION:The workshops are full\, register to wait in line for an empty spot. \n\n\n\nThe marketplace at 14:30 is open for all\, welcome! \n\n\n\nLocation: Rönnen – Campus University Hospital – Linköping University. On-site event arranged by SciLifeLab Linköping \n\n\n\n\nRegister here\n\n\n\n\nNote: It is important to bring a laptop to actively participate in the workshops. \n\n\n\nDiscover how to effectively manage\, share\, and safeguard your research data through practical guidance from both local and national experts. Engage in discussions on best practices grounded in the FAIR principles and Open Science. \n\n\n\nSciLifeLab Data Centre\, National Bioinformatics Infrastructure Sweden (NBIS) and the LiU legal office welcome all life-science researchers and infrastructure experts in Linköping to join this event where we explore support for research data handling\, GDPR and data management practices according to Findable\, Accessible\, Interoperable and Reusable (FAIR) principles and Open Science. \n\n\n\nWe specifically invite SciLifeLab Group leaders\, Fellows and WCMM Fellows\, and all PhD´s and PostDocs in their research groups to join this interactive event. \n\n\n\nThis event is informal and inclusive\, so feel welcome to join and participate in our interesting discussions! \n\n\n\nPROGRAM\n\n\n\nNote: It is important to bring a laptop to actively participate in the workshops. \n\n\n\n10.00-10.15: Welcome coffee/tea\nEveryone is welcome for the coffee/tea. You can just walk in between 10.00-10.15. \n\n\n\n\n10.15-10.30: Introduction\nIntroduction of the program. \n\n\n\n\n10:30-12:00: Writing a strong Data Management Plan (DMP) – Improving the lifecycle of your research data\nManaging research data involves a complex web of decisions. How do you ensure nothing falls through the cracks and that your data remains FAIR? The answer is a Data Management Plan (DMP). \n\n\n\nThis hands-on workshop emphasises data management planning at all project phases to keep your data secure and organised. Participants will gain direct access to the Data Stewardship Wizard (DSW) tool to begin drafting a customised DMP tailored to life science research projects. \n\n\n\nRelated content \n\n\n\n \n\n\n\n\n12.00-13.00: Lunch break\nLunch is not included in this event. At Linköping University and the surrounding campus you will find several options for lunch. \n\n\n\n\n13.00-14.30: Handling personal data in Life Science – Navigating GDPR and Swedish legislation\nAre you confident in how your research project documents and processes personal data? This seminar guides you through the legal landscape\, from the GDPR to specific Swedish national laws. Using a practical research scenario\, we will clarify essential roles and terms\, including: \n\n\n\n\nResearch principal (forskningshuvudman): Understanding the role and responsibilities of the organisation hosting the research.\n\n\n\nData controllers vs. processors: Identifying who is responsible for each stage of data processing.\n\n\n\nSensitive data: Best practices for securely sharing biomedical research data in FEGA Sweden while remaining compliant.\n\n\n\n\n\n14.30-15.15: Marketplace: an interactive exhibition – including fika for registered participants\nVisit the Interactive Marketplace to explore local and national research data management services in an engaging and informal setting. Meet experts\, discover practical support and tools\, join interactive discussions\, and learn how different services can support your research.Interested in contributing to the Marketplace and showcasing your data management support services? Please contact josefine.sandstrom@liu.se. \n\n\n\n\n15.15-17.00: Open source software for research – Sharing code the right way\nResearch depends on software\, but without open and FAIR practices\, software can be difficult to understand\, reproduce\, and reuse. Open-source software means code that is not only available\, but also licensed for free use\, modification\, and sharing. This workshop provides an overview of open science and FAIR software practices\, and introduces a practical checklist for open and FAIR research software. Participants will apply these principles in a hands-on tutorial to improve the openness\, transparency\, and reusability of their research code. \n\n\n\n\n17.00: End of the event\nThe event will end at 17.00. Thank you all for participating. \n\n\n\n\n \n\n\n\nMore information on Research Data Management and Open Science\n\n\n\nResearch Data Management (RDM) concerns the organization\, storage\, preservation\, and sharing of data that is collected and analyzed during a research project. Proper planning and management of research data will make project management easier and more efficient while projects are being performed. It also facilitates sharing and allows others to validate as well as reuse the data. \n\n\n\nOpen Science is a set of principles and practices that aim to make scientific research from all fields accessible to everyone for the benefits of scientists and society as a whole. Open science is about making sure not only that scientific knowledge is accessible but also that the production of that knowledge itself is inclusive\, equitable and sustainable. \n\n\n\nContact information: NBIS\, SciLifeLab Data Centre – Data Management\, and SciLifeLab Linköping. For questions\, please contact josefine.sandstrom@liu.se URL:https://www.scilifelab.se/event/research-data-management-day-in-linkoping/ CATEGORIES:Event ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2025/05/OpenScience-scaled.jpeg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20260922T151500 DTEND;TZID=Europe/Stockholm:20260922T161500 DTSTAMP:20260904T154010Z CREATED:20260904T153541Z LAST-MODIFIED:20260904T154010Z UID:10001887-1790090100-1790093700@www.scilifelab.se SUMMARY:New Approaches to Characterize the Chemical Exposome DESCRIPTION:Spotlight Seminar Series warmly welcomes Professor David S. Wishart from the University of Alberta\, Canada to give a talk at SciLifeLab Campus Solna. \n\n\n\n\n\n\n\nAbstract\n\n\n\nThe chemical exposome constitutes a large and incredibly diverse chemical universe. It includes compounds derived from food\, food additives\, cosmetics\, pharmaceuticals\, consumer products\, dyes\, pesticides\, industrial chemicals\, and environmental pollutants. With more than 20 million compounds estimated to constitute the chemical exposome\, its characterization represents an enormous analytical and computational challenge. In this seminar\, I will describe our efforts to define\, catalogue\, measure\, and predict this vast chemical space. I will first discuss our development and curation of exposome resources\, including T3DB\, FooDB\, the NORMAN Suspect List Exchange\, and SYNCED\, the Synthetic Chemical Exposome Database. Together\, these resources connect known exposure chemicals with their sources\, physicochemical properties\, biological targets\, toxicities\, and health effects. I will then present QUANTEX 600\, our quantitative mass spectrometry assay for measuring hundreds of selected exposome compounds in biospecimens. Although targeted assays provide measurement of known chemicals\, much of the exposome remains unidentified “dark matter.” To address this gap\, we are introducing the concept of in silico exposomics\, an untargeted strategy that combines databases\, artificial intelligence\, spectral prediction\, and analytical chemistry to illuminate the exposome’s dark matter. This concept uses chemical language models (CLMs) and metabolism prediction tools (BioTransformer) to predict novel exposure compounds and their metabolic products. In silico exposomics also involves predicting tandem mass spectra\, chromatographic retention times\, electron-ionization mass spectra\, and retention indices of these predicted or expected compounds\, thereby enabling these unrecognized chemicals to be detected and identified experimentally. I will provide examples of how successful this strategy appears to be and suggestions of where it may lead \n\n\n\nBiography\n\n\n\nDavid Wishart earned his PhD in Molecular Biophysics from Yale University in 1991 and joined the University of Alberta as an assistant professor in 1995\, becoming a full professor in 2003. He is currently a Distinguished University Professor in the Departments of Biological Sciences and Computing Science\, with adjunct appointments in the Faculty of Pharmacy and Pharmaceutical Sciences and the Department of Laboratory Medicine and Pathology. He holds a Tier 1 Canada Research Chair in Metabolomics and Precision Medicine. Wishart’s multidisciplinary research spans metabolomics\, exposomics\, precision medicine\, precision nutrition\, bioinformatics\, cheminformatics\, structural biology\, artificial intelligence\, robotics and analytical chemistry. His work has enabled the identification and quantification of metabolites in complex biological samples\, the discovery of biomarkers for cancer\, cardiovascular disease\, neurological disorders\, infectious disease\, organ dysfunction and environmental exposure\, and the development of computational tools for predicting molecular structures\, properties\, spectra\, metabolic pathways and biological activities. After pioneering computational approaches for interpreting NMR spectra of biofluids in 1999\, Wishart helped establish metabolomics as a major scientific discipline. In 2005\, he launched the Human Metabolome Project and subsequently created the Human Metabolome Database. His laboratory has developed more than 100 freely accessible databases and software tools\, including HMDB\, DrugBank\, FooDB\, MetaboAnalyst\, CFM-ID\, BioTransformer\, PathBank and NP-MRD\, which are used by millions of researchers worldwide. In 2011\, he co-founded The Metabolomics Innovation Centre (TMIC)\, Canada’s national metabolomics laboratory\, which now includes eight research nodes\, employs more than 30 scientists and houses over $35 million in equipment. He has also helped launch more than a dozen biotechnology companies\, including BioTools\, Chenomx and Molecular You. Wishart has authored or co-authored nearly 700 publications\, received more than 166\,000 citations and attained an h-index of 155. His honours include election to the Royal Society of Canada in 2017\, appointment as Distinguished University Professor in 2018\, the J. Gordin Kaplan Award in 2023\, the NSERC Brockhouse Prize in 2024\, the University Cup and NSERC Herzberg Gold Medal in 2025\, and a Governor General’s Innovation Award in 2026. \n\n\n\n \n\n\n\nHost: Jonathan Martin jon.martin@aces.su.se URL:https://www.scilifelab.se/event/new-approaches-to-characterize-the-chemical-exposome/ LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden CATEGORIES:Event ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2023/10/Campus-solna-seminar-picture.jpg ORGANIZER;CN="Spotlight Seminar Series":MAILTO:events@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20260924T120000 DTEND;TZID=Europe/Stockholm:20260924T130000 DTSTAMP:20260819T123315Z CREATED:20260819T115756Z LAST-MODIFIED:20260819T123315Z UID:10001864-1790251200-1790254800@www.scilifelab.se SUMMARY:Campus Solna Seminar Series: Taobo Hu & Havva Ozlem Altay DESCRIPTION:Welcome to join the Campus Solna Seminar Series – an initiative to promote the fantastic science ongoing at Campus Solna and hopefully forge more internal communication and collaboration between within Campus Solna. The format consists of two 20 min talks (One speaker from the Alpha-building and one from the Gamma-building respectively)\, with an additional 5 min of questions. Presentation of ongoing (unpublished) projects is strongly encouraged. \n\n\n\nThe seminars are held Thursdays 12:00-13:00. You can bring your lunch to the seminar. \n\n\n\nPhD students that are attending the Campus Solna Seminar lectures will have the opportunity to gain credits. For the syllabus and instructions on how to obtain these credits\, read this document. Please contact your own department at your host University to confirm.See here the full schedule for this semester. \n\n\n\nThis week:\n\n\n\n\n\n\nTaobo Hu\n\n\n\nMats Nilsson – gamma 4 \n\n\n\n \n\n\n\n\n\nHavva Ozlem Altay\n\n\n\nAdil Mardinoglu – alpha 6 \n\n\n\n \n\n\n\n\n\n\nThis seminar series is organized by the PhD & Postdoc Council. For more information about the Council and other events check our page. URL:https://www.scilifelab.se/event/campus-solna-seminar-series-24sept/ LOCATION:Milkyway SciLifeLab Solna\, Tomtebodavägen 23\, Solna CATEGORIES:Community ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2022/12/IMG_4110-scaled.jpg ORGANIZER;CN="SciLifeLab Solna PhD & Postdoc Council":MAILTO:phd-council@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20261001T120000 DTEND;TZID=Europe/Stockholm:20261001T130000 DTSTAMP:20260819T123304Z CREATED:20260819T115930Z LAST-MODIFIED:20260819T123304Z UID:10001865-1790856000-1790859600@www.scilifelab.se SUMMARY:Campus Solna Seminar Series: Baizhen Chen & Anna Schuppe DESCRIPTION:Welcome to join the Campus Solna Seminar Series – an initiative to promote the fantastic science ongoing at Campus Solna and hopefully forge more internal communication and collaboration between within Campus Solna. The format consists of two 20 min talks (One speaker from the Alpha-building and one from the Gamma-building respectively)\, with an additional 5 min of questions. Presentation of ongoing (unpublished) projects is strongly encouraged. \n\n\n\nThe seminars are held Thursdays 12:00-13:00. You can bring your lunch to the seminar. \n\n\n\nPhD students that are attending the Campus Solna Seminar lectures will have the opportunity to gain credits. For the syllabus and instructions on how to obtain these credits\, read this document. Please contact your own department at your host University to confirm.See here the full schedule for this semester. \n\n\n\nThis week:\n\n\n\n\n\n\nBaizhen Chen\n\n\n\nCecilia Williams – alpha \n\n\n\n \n\n\n\n\n\nAnna Schuppe\n\n\n\nPer-Olof Syren – gamma 5 \n\n\n\n \n\n\n\n\n\n\nThis seminar series is organized by the PhD & Postdoc Council. For more information about the Council and other events check our page. URL:https://www.scilifelab.se/event/campus-solna-seminar-series-1oct/ LOCATION:Milkyway SciLifeLab Solna\, Tomtebodavägen 23\, Solna CATEGORIES:Community ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2022/09/IMG_20221103_120135408_HDR-scaled.jpg ORGANIZER;CN="SciLifeLab Solna PhD & Postdoc Council":MAILTO:phd-council@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20261002T083000 DTEND;TZID=Europe/Stockholm:20261002T163000 DTSTAMP:20260911T115249Z CREATED:20260316T134245Z LAST-MODIFIED:20260911T115249Z UID:10001772-1790929800-1790958600@www.scilifelab.se SUMMARY:AI Frontiers in Life Sciences: From Models to Meaning DESCRIPTION:Image by Andreas Bergfeldt \n\n\n\nDate and time: October 2\, 2026 at 8.30-16.30 CET \n\n\n\nLocation: Humanistiska teatern – Uppsala\, onsite and livestream via Zoom \n\n\n\nThe AI Frontiers in Life Sciences: From Models to Meaning symposium will bring together experts in artificial intelligence (AI) and life sciences to explore emerging directions\, challenges\, and opportunities for AI in life science research. \n\n\n\nThe symposium will feature presentations\, demonstrations\, and panel discussions with leading international and Swedish experts. The event is intended for researchers\, infrastructure experts\, and professionals interested in AI-driven life science research. Discussions will also provide input to the continued development of the SciLifeLab AI Strategy and ongoing and planned activities across SciLifeLab. \n\n\n\nFurther details\, including the full programme\, will be announced soon. \n\n\n\nRegistration: \n\n\n\nRegistration \n\n\n\nParticipation is free of charge and places are allocated on a first-come\, first-served basis. Refreshments and lunch will be provided for on-site participants. \n\n\n\nIn-person places are limited. If in-person registration is full\, you are welcome to join the waiting list or register to attend the event via the Zoom livestream. \n\n\n\nIf you register to join the talks via Zoom\, you will receive the livestream link on the day of the event. Please note that the talks will be streamed live only and will not be recorded or made available afterwards. \n\n\n\nRegister Here\n\n\n\nWaiting List \n\n\n\nIf we reach full capacity for in-person attendance\, a waiting list will be activated. If you join the waiting list\, you will automatically receive an email if a place becomes available. \n\n\n\nYou will need to accept the offer to secure your place. If you decline\, the place will be offered to the next person on the waiting list. \n\n\n\nCancellation \n\n\n\nTo help us minimise empty seats and food waste\, please cancel your registration if you are no longer able to attend the event. If a waiting list is active\, this will allow us to offer your place to another participant. Timely cancellations also help us avoid unnecessary costs for refreshments and lunch. \n\n\n\nIf you have questions\, please contact datacentre@scilifelab.se \n\n\n\nSpeakers: \n\n\n\nAnna Kreshuk\, EMBL\nInterim Head of Cell Biology and Biophysics Unit \n\n\n\nAnna Kreshuk is a Group Leader and Senior Scientist at the European Molecular Biology Laboratory (EMBL) in Heidelberg\, where she develops computer vision methods for the analysis of microscopy images. She contributes to open-source tools including ilastik and PlantSeg and is an ELLIS Scholar and scientific co-coordinator of the Horizon Europe project AI4Life. She has served as Interim Head of EMBL’s Cell Biology and Biophysics Unit since 2024. \n\n\n\nWeb: Kreshuk Group \n\n\n\n\nFlorian Jug\, Human Technopole\nHead of Computational Biology Research Centre – Multimodal AI Across Scales\, Computational biology\, Research Group Leader\,  \n\n\n\nDr. Florian Jug holds a PhD in Computational Neuroscience from the Institute of Theoretical Computer Science at ETH Zurich. His research aims at pushing the boundary of what AI and machine learning can do to better analyze and quantify biological data. At HT\, Dr. Jug covers the full breadth of bio-image computing\, from research on novel methods for computer vision and machine learning\, all the way to offering bio-image analysis as a service. \n\n\n\nWeb: Jug Group \n\n\n\n\nHeidi Howard\, Chalmers University of Technology & SciLifeLab\nBioethicist and ELSI Lead \n\n\n\nHeidi Howard is a bioethicist and ELSI (Ethical\, Legal and Social Issues) Lead at SciLifeLab and the Data-Driven Life Science (DDLS) programme. Her work focuses on the ethical\, legal and social implications of data-driven life science and AI\, with experience in AI ethics\, policy and safety. \n\n\n\n\nKadi Liis Saar\, Recursion\nScientific Leader and Associate Principal Scientist\, Recursion\, a company focused on AI-driven solutions in drug discovery. \n\n\n\nDr. Kadi Liis Saar is the Scientific Leader and Associate Principal Scientist\, Computational Biology & Data Science at Recursion\, and elected member of Estonian Young Academy of Science. Dr. Saar is an interdisciplinary scientist and inventor with a background in chemical engineering and biotechnology (BA & MEng) and biophysical chemistry (PhD University of Cambridge 2018). Previously at Transition Bio\, she was a Junior Research Fellow at St. John’s College\, University of Cambridge and a Schmidt Science Fellow working between the Centre for Misfolding Diseases and the Maxwell Centre 2018-2022. \n\n\n\nWeb: Recursion \n\n\n\n\nSamuel Kaski\, ELLIS Institute Finland\nFounding Director\, ELLIS Institute Finland \n\n\n\nSamuel Kaski is the founding director of ELLIS Institute Finland and leads the Finnish Center for Artificial Intelligence (FCAI). He is Professor of Machine Learning at Aalto University and Professor of Artificial Intelligence at the University of Manchester. His research focuses on probabilistic machine learning and collaborative AI\, with applications in health\, medicine and biology. \n\n\n\nWeb: Kaski Lab \n\n\n\n\nSebastian Lobentanzer\, Helmholtz Center Munich \nPrincipal Investigator\, Computational Health Center \n\n\n\nSebastian Lobentanzer is a PI at the Computational Health Center at Helmholtz Center Munich since 2025\, and in affiliation with the Open Targets group at the European Bioinformatics Institute (EMBL-EBI) since 2024. Sebastian serves as the head of computational biology at the German Center for Diabetes Research. He is the author of BioCypher – https://biocypher.org/ \, BioChatter – https://biochatter.org/ projects. \n\n\n\nWeb: Lobentanzer Lab \n\n\n\n\nSymposium Programme \n\n\n\n\n\n\n\nHumanistiska teatern \n\n\n\n\n\n\n\n\n\n\n\n\n\nOrganisers: SciLifeLab Data Centre datacentre@scilifelab.se URL:https://www.scilifelab.se/event/ai-frontiers-in-life-sciences-from-models-to-meaning/ LOCATION:Humanistiska teatern\, Uppsala\, Thunbergsvägen 3C\, Uppsala\, 75238\, Sweden CATEGORIES:Event ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2026/03/AI-Frontiers-Feature-Image.png ORGANIZER;CN="SciLifeLab Data Centre":MAILTO:datacentre@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20261008T120000 DTEND;TZID=Europe/Stockholm:20261008T130000 DTSTAMP:20260819T123256Z CREATED:20260819T121103Z LAST-MODIFIED:20260819T123256Z UID:10001866-1791460800-1791464400@www.scilifelab.se SUMMARY:Campus Solna Seminar Series: Selim Tanriverdi & Sofie Blahova DESCRIPTION:Welcome to join the Campus Solna Seminar Series – an initiative to promote the fantastic science ongoing at Campus Solna and hopefully forge more internal communication and collaboration between within Campus Solna. The format consists of two 20 min talks (One speaker from the Alpha-building and one from the Gamma-building respectively)\, with an additional 5 min of questions. Presentation of ongoing (unpublished) projects is strongly encouraged. \n\n\n\nThe seminars are held Thursdays 12:00-13:00. You can bring your lunch to the seminar. \n\n\n\nPhD students that are attending the Campus Solna Seminar lectures will have the opportunity to gain credits. For the syllabus and instructions on how to obtain these credits\, read this document. Please contact your own department at your host University to confirm.See here the full schedule for this semester. \n\n\n\nThis week:\n\n\n\n\n\n\nSelim Tanriverdi\n\n\n\nAman Russom – alpha \n\n\n\n \n\n\n\n\n\nSofie Blahova\n\n\n\nBjörn Önfelt – gamma 3 \n\n\n\n \n\n\n\n\n\n\nThis seminar series is organized by the PhD & Postdoc Council. For more information about the Council and other events check our page. URL:https://www.scilifelab.se/event/campus-solna-seminar-series-8oct/ LOCATION:Milkyway SciLifeLab Solna\, Tomtebodavägen 23\, Solna CATEGORIES:Community ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2022/09/IMG_20221103_120135408_HDR-scaled.jpg ORGANIZER;CN="SciLifeLab Solna PhD & Postdoc Council":MAILTO:phd-council@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20261008T130000 DTEND;TZID=Europe/Stockholm:20261008T140000 DTSTAMP:20260907T060217Z CREATED:20260907T060131Z LAST-MODIFIED:20260907T060217Z UID:10001888-1791464400-1791468000@www.scilifelab.se SUMMARY:BiG Talk:  Pioneering chromatin landscapes in embryo development – epigenomic methods reveal how gene expression patterns are formed and maintained DESCRIPTION:Professor Mattias Mannervik\, Department of Molecular Biosciences\, The Wenner-Gren Institute\, Stockholm University. \n\n\n\nAbstract \n\n\n\nUnderstanding how chromatin state contributes to developmental trajectories remains central to deciphering cell specification and differentiation. In this talk\, I will discuss how studying chromatin biology with genomic methods at the bulk and single-cell level informs on embryo development and formation of different cell types. Immediately after fertilization\, the genome is transcriptionally quiescent. Maternally encoded pioneer factors reprogram the chromatin state and facilitate transcription of the zygotic genome. In Drosophila\, transcription is initiated by the pioneer factor Zelda. While Zelda-occupied sites are enriched with histone acetylation\, a post-translational mark associated with active cis-regulatory regions\, the functional relationship between Zelda and histone acetylation remained unclear. We show that Zelda-mediated recruitment of the histone acetyltransferase CREB-binding protein (CBP) is essential for zygotic transcription. Further\, using dual-modality nano-CUT&Tag\, we profiled two antagonistic histone modifications—active H3K27ac and repressive H3K27me3—in thousands of single cells from Drosophila embryos across early lineage diversification and terminal differentiation. Joint embedding of both marks enabled robust cell-type classification and revealed increasing epigenetic specificity over developmental time. We ordered cells by developmental age and epigenomic similarity\, and defined an epigenetic potential metric that visualizes repressive chromatin barriers as landscapes that predict transcriptional activity. These findings demonstrate that cell-type-specific deployment of H3K27ac and H3K27me3 sculpts epigenetic potential landscapes that help shape developmental gene expression patterns. \n\n\n\nBiography \n\n\n\nMattias Mannervik is Professor of Molecular Developmental Biology at the Department of Molecular Biosciences\, The Wenner-Gren Institute\, Stockholm University. By combining powerful Drosophila genetics with genomic technologies\, his research focuses on how chromatin and transcription influence each other\, and how the resulting gene expression patterns shape embryo development. His interest in transcriptional regulation began already during his undergraduate studies\, and his Ph.D. work with Professor Göran Akusjärvi at Uppsala University focused on how adenoviruses use the host cell machinery to control transcription. He then turned to a model where genetics could be applied to studies of transcriptional control\, and did his postdoctoral work in Professor Mike Levine´s laboratory at University of California\, Berkeley\, USA\, where he studied transcriptional co-regulators in Drosophila embryo development. Returning to Sweden in year 2000\, he established his independent laboratory at Stockholm University. Genetic screens and reverse genetic approaches uncovered novel regulators of gene expression in Drosophila embryos\, and for more than 15 years genomic and epigenomic methods have been the cornerstone of his research. This has led to discoveries such as a unique histone 3 lysine 14 chromatin signature that underlies tissue-specific gene regulation\, that gene regulation can occur independently of chromatin conformation\, and that the CBP co-activator has an unexpected function in epigenetic gene silencing by Polycomb proteins. \n\n\n\nHost: Agata Smialowska\, NBIS (agata.smialowska@nbis.se) \n\n\n\nBroadcast link (live event):  https://lu-se.zoom.us/j/64561309877 \n\n\n\nThe talk is sponsored by the NBIS course Epigenomics Data Analysis. \n\n\n\nA recording  will also be available on the NBIS YouTube channel. URL:https://www.scilifelab.se/event/big-talk-pioneering-chromatin-landscapes-in-embryo-development-epigenomic-methods-reveal-how-gene-expression-patterns-are-formed-and-maintained/ LOCATION:Online event via Zoom CATEGORIES:Event ORGANIZER;CN="BiG Talks":MAILTO:info@nbis.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20261012T120000 DTEND;TZID=Europe/Stockholm:20261014T120000 DTSTAMP:20260507T093008Z CREATED:20260414T090237Z LAST-MODIFIED:20260507T093008Z UID:10001802-1791806400-1791979200@www.scilifelab.se SUMMARY:WASP-HS & DDLS: Interdisciplinary Workshop DESCRIPTION:WASP-HS & DDLS: Joint Workshop at Sigtunastiftelsen\, 12–14 October \n\n\n\nThis interdisciplinary workshop brings together a carefully selected group of 25 researchers from diverse fields to exchange perspectives on the ethical\, legal\, and social dimensions of data-intensive research in the life sciences. The conversation is not limited to lawyers and ethicists\, but also includes researchers whose work both shapes and is shaped by these governance frameworks. \n\n\n\nThe aim is to bring together diverse expertise to explore key challenges\, frame shared research questions\, and spark new interdisciplinary collaborations. \n\n\n\nWorkshop Focus\n\n\n\n→ Analyze governance structures and how they shape data-intensive research in precision medicine\, epidemiology\, infection biology\, biodiversity\, and molecular life sciences→ Identify key legal\, regulatory\, and ethical challenges in data-driven life sciences\, with particular attention to the experiences of scientists working with these issues in practice→ Promote meaningful dialogue across disciplines→ Develop new interdisciplinary research initiatives \n\n\n\nDuration\n\n\n\n12 OctoberArrival and opening from lunch onwards \n\n\n\n13 OctoberFull day of sessions \n\n\n\n14 OctoberClosing and departure ending with lunch  \n\n\n\nExpression of Interest\n\n\n\nApply by May 14 to secure your spot. This workshop is open to researchers from both the WASP-HS and DDLS communities. Spots are limited to 25 participants\, so make sure to fill in the Expression of Interest form to get a chance to attend. \n\n\n\nApply here \n\n\n\nOrganizers\n\n\n\nLianne Colonna\,WASP-HS\, Stockholm UniversityYana Litins’ka\, WASP-HS\, Lund UniversityHeidi Howard\, DDLS\, Chalmers University of TechnologyFrancis Lee\, WASP-HS\, Södertörn UniversityUlrika Wallenquist\, DDLS\, Uppsala UniversityBodil Formark\,WASP-HS\, Södertörn University URL:https://www.scilifelab.se/event/wasp-hs-ddls-interdisciplinary-workshop/ LOCATION:Sigtunastiftelsen\, Manfred Björkquists allé 4\, Sigtuna\, 193 31\, Sweden CATEGORIES:Event ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2025/11/DDLS.jpg ORGANIZER;CN="Data-Driven Life Science @ SciLifeLab":MAILTO:ddls@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20261013T090000 DTEND;TZID=Europe/Stockholm:20261013T183000 DTSTAMP:20260909T100640Z CREATED:20251219T143433Z LAST-MODIFIED:20260909T100640Z UID:10001690-1791882000-1791916200@www.scilifelab.se SUMMARY:The PROMISE Initiative: Accelerating Cancer Innovation DESCRIPTION:This conference focuses on the PROMISE Cancer effort led by Swedish scientists representing Stockholm\, Uppsala\, Umeå\, Linköping\, Lund\, and Gothenburg as well as SciLifeLab. \n\n\n\nCancer encompasses more than 200 distinct diseases\, each with widely varying prognoses\, ranging from highly treatable to aggressive cancers with poor outcomes. Advances in molecular profiling hold great promise for improving diagnostics and treatment by enabling more precise\, personalized approaches tailored to individual patients. Sweden has world-leading cancer registries and high-quality biobanks\, creating unique opportunities for cancer research. By joining forces across the research community\, we can better leverage these national strengths to benefit patients. SciLifeLab platforms support the generation\, integration\, and analysis of data across genomics and a broad range of other omics technologies. \n\n\n\nThe goal of the conference is to expand the PROMISE Cancer initiative\, promote its efforts\, and continue building the Swedish cancer community. \n\n\n\nRegistration\n\n\n\nRegister here\n\n\n\nAbout PROMISE\n\n\n\nPrecision Omics Initiative Sweden (PROMISE) is a national initiative using genomics and multiomics to understand common diseases\, rare diseases\, and cancer. \n\n\n\nRead more about PROMISE\n\n\n\nProgram and speakers\n\n\n\n\n\n\n\nMike Stratton\, Sanger Institute\nMike Stratton qualified in medicine at Oxford University and Guy’s Hospital Medical School and obtained a PhD in the Molecular Biology of Cancer at the Institute of Cancer Research\, London. His research into the genomes of normal and cancer cells includes discovery of the breast cancer susceptibility gene BRCA2\, of somatically mutated BRAF in malignant melanoma\, and establishing the conceptual and analytic framework of mutational signatures. He is a Fellow of the Royal Society\, an International Member of the US National Academy of Sciences and was Knighted in the 2013 Queen’s birthday honours. \n\n\n\n\nThoas Fioretos\, Lund University\nThoas Fioretos\, MD\, PhD\, is Professor of Clinical Genetics at Lund University and Senior Consultant at Skåne University Hospital. His research focuses on the molecular basis of acute leukemia and its translation into improved diagnostics and targeted therapies. His group applies genomic and single-cell approaches to define cell states\, stem-cell properties\, immune-evasion mechanisms and cell-surface targets. The group was among the first to establish IL1RAP as a therapeutic target on leukemia stem cells and recently identified SLAMF6 as an immune checkpoint in acute myeloid leukemia. These discoveries have supported antibody-based therapies\, including an investigator-initiated trial evaluating an IL1RAP-targeting antibody in AML and high-risk MDS at MD Anderson Cancer Center. Fioretos is a Wallenberg Clinical Scholar\, Platform Scientific Director of Clinical Genomics Lund at SciLifeLab and a founding member of Genomic Medicine Sweden. He is a member of the Royal Swedish Academy of Sciences and currently chairs its Class for Medical Sciences. \n\n\n\n\nShahar Alon\, Bar-Ilan University\nDr. Shahar Alon leads the Spatial Genomics lab at the Faculty of Engineering\, Bar-Ilan University. Dr. Alon background is in Physics and Neuroscience\, with a PhD from Tel Aviv University\, and a postdoc in the group of Prof. Ed Boyden at MIT. Dr. Alon was awarded the LSRF scholarship during his postdoc and the ERC starting grant as a principal investigator. Alon’s group research questions are mainly related to RNA localization in neurons in healthy and disease-related tissues as well as in cancer tissues. Alon’s group builds technologies and data analysis tools for spatial single cell analysis. \n\n\n\n\nEsther Rheinbay\, Harvard Medical School\nEsther Rheinbay is an Assistant Professor of Medicine at Harvard Medical School and a Principal Investigator at the Krantz Family Center for Cancer Research at Massachusetts General Hospital. She is also an Associate Member of the Broad Institute of MIT and Harvard. Dr. Rheinbay’s research focuses on the intersection of cancer genomics and epigenomics\, with a particular interest in understanding how non-coding mutations and large-scale chromosomal alterations drive tumor progression. Her group is also interested in the role of the sex chromosomes\, and specifically the Y chromosome in cancer. Dr. Rheinbay earned her undergraduate degree in Bioinformatics from the University of Tübingen and her Ph.D. from Boston University\, where she specialized in computational epigenomics. She completed her postdoctoral training at the Broad Institute. Beyond the lab\, Dr. Rheinbay is an advocate for supporting parent scientists in academia\, and enjoys teaching the creativity of designing effective scientific figures. \n\n\n\n\nKarin Forsberg Nilsson\, Uppsala University\nKarin Forsberg-Nilsson is Professor of Stem Cell Research at Uppsala University\, Sweden\, and a SciLifeLab Group Leader. She received her PhD from Uppsala University in 1992 followed by a postdoc at the National Institutes of Health\, USA. Alongside her research\, she has held leadership positions in the pharma/biotech sector\, the Swedish Research Council\, SciLifeLab\, and Uppsala University\, most recently serving as Dean of the Faculty of Medicine. Her research focuses on the intersection of cancer and neurobiology\, combining neural stem cell biology with expertise in brain tumor biology and genetics. Her laboratory investigates non-coding mutations in brain tumors\, with a particular focus on regulatory regions under evolutionary constraint. This work is based on the hypothesis that conserved genomic regions are more likely to be functional and that mutations within them may have greater biological impact. \n\n\n\n\nMargareta Haag\, Swedish Network Against Cancer\nMargareta Haag is Chair of the Swedish Network against Cancer\, an umbrella organization for cancer patient organizations and their families. A lymphoma patient since 1994 and a lymphoedema patient since 1995\, she is a strong patient representative and advocate. She is former Executive Director of an international professional body and the Federation of Biomedical Laboratory Science. Her leadership roles include President of the Swedish Association of Chronic Oedema and former member of the Swedish Ministry of Social Affairs’ Patient Advisory Council (2019–2021). Margareta has also contributed to the Government’s Innovation Partnership Programme in Health and Life Science\, focusing on precision medicine and ATMPs. She serves or has served on several patient and health-related boards and advisory groups\, including All.Can Sweden\, GPCC\, EUPATI Sweden\, Agenda for Health and Well-being\, Research Sweden\, Patient Advocacy 2.0\, and Zero Vision Cancer. \n\n\n\n\nAnn Nordgren\, Karolinska Institutet\n \n\n\n\n\nJohan Lindberg\, Karolinska Institutet\nJohan Lindberg is Principal Researcher at the Department of Medical Epidemiology and Biostatistics\, Karolinska Institutet. His research covers cancer genomics\, bioinformatics\, assay development\, biomarker discovery\, and clinical trials. He has established an infrastructure and a team that performs prospective genomic analysis of cancer genomes and delivers results within a clinically relevant timeframe. More than 6500 reports have been sent to approximately 50 hospitals in six European countries. He is responsible for the prospective genomic analysis in the ProBio Biomarkers trial (NCT03903835)\, an outcome-adaptive randomised platform trial in metastatic prostate cancer (Nature Medicine\, 2024)\, and held the same responsibility in the ALASCCA trial which evaluated low-dose aspirin in PI3K-altered localised colorectal cancer (New England Journal of Medicine\, 2025). Assays developed in these programmes are currently in routine diagnostic use at Karolinska University Hospital for metastatic prostate cancer and six further diagnoses. \n\n\n\n\nOlli Kallioniemi\, Institute for Molecular Medicine Finland (FIMM)\nOlli Kallioniemi is Research Director at the Institute for Molecular Medicine Finland (FIMM)\, part of HiLIFE at the University of Helsinki. He earned his MD (1985)\, PhD (1988)\, and specialization in Clinical Chemistry (1990) from the University of Tampere. He then spent 11 years in the U.S. as a postdoctoral fellow at UCSF and tenure-track investigator at NHGRI/NIH\, where he was tenured in 2001. From 2007–2015\, he served as the founding director of FIMM in Helsinki\, later recruited to Sweden to direct the Science for Life Laboratory (SciLifeLab) in 2015–2024\, Sweden´s national life science research infrastructure\, as well as nominated to a professorship in molecular precision medicine at Karolinska Institutet. He also acted as the Founding Director of the 3.3B SEK SciLifeLab-KAW Data-Driven Life Science (DDLS) program. His research focuses on AI- and data-driven precision medicine\, particularly in acute myeloid leukemia and prostate cancer\, and he co-leads a national initiative to plan the future of Finnish health data space and its utilization. He has authored 420+ publications\, holds ~20 patents\, and supervised 27 doctoral theses and over 30 postdocs. His honors include the Anders Jahre Young Investigator Award\, Äyräpää Prize\, AACR Team Science Awards\, and Biomedicum Medal. He is a member of EMBO\, the European Academy of Cancer Sciences\, the Royal Swedish Academy of Sciences\, and the Nobel Assembly at Karolinska Institutet. \n\n\n\n\nBerend Snijder\, Institute of Molecular Systems Biology\, ETH Zürich\nBerend Snijder is a Faculty Member at the Botnar Institute of Immune Engineering. He is a group leader at the Swiss Institute of Bioinformatics and the Comprehensive Cancer Center Zurich\, and was previously Assistant Professor at the Institute of Molecular Systems Biology at the ETH Zurich. Berend’s research focuses on the systematic functional and multi-omic profiling of human tissues in health and disease\, with strong bioinformatics and clinical/translational focus. He is a leading figure in the field of functional precision medicine. Berend has co-founded three spinoff companies\, including Allcyte (acquired by Exscientia\, now Recursion)\, Prevision Medicine\, and Graph Therapeutics. \n\n\n\n\nTuuli Lappalainen\, KTH & New York Genome Center\nTuuli Lappalainen\, PhD\, is a Professor at KTH Royal Institute of Technology\, the Director of the Genomics Platform and the National Genomics Infrastructure of SciLifeLab\, Sweden\, and a Senior Associate Faculty Member at the New York Genome Center. Dr. Lappalainen received her PhD in Genetics from the University of Helsinki. Her research focuses on molecular and cellular effects of genetic variation in human populations and their contribution to human traits and diseases. She has contributed to many international research consortia in human genetics\, and she has received multiple prizes for her contributions to the field. \n\n\n\n\nTobias Sjöblom\, Uppsala University\nTobias Sjöblom is Professor of Tumor Genetics at Uppsala University\, Sweden. His current research interests include the somatic genetic basis of colorectal cancer\, phenotypes of cancer mutations\, and diagnostics and therapeutics development based on somatic mutations. He is Program Director for U-CAN\, a longitudinal cancer research initiative encompassing >30.000 patients to support cancer biomarker research. \n\n\n\n\nLao Saal\, Lund University\nDr. Lao Saal\, MD/PhD\, is Head of Translational Oncogenomics\, Division of Oncology\, at Lund University\, and is the Co-Director of the CIRCE Women’s Cancer Research Center and Head of SCAN-B Translational Research. He was also founder and CEO of SAGA Diagnostics\, a spinout company from his laboratory that focused on circulating tumor DNA liquid biopsy testing\, and which was acquired by Foundation Medicine / Roche for up to 595 MUSD\, and is the consulting Medical Director for the AI digital pathology company DoMore Diagnostics. Dr. Saal has MD and PhD degrees from Columbia University (New York) and has trained at the U.S. National Institutes of Health and Memorial Sloan Kettering Cancer Center\, and has published more than 80 articles\, including in leading journals such as Nature Genetics\, Science\, and PNAS\, which in total have been cited more than 15\,000 times. \n\n\n\n\nJohanna Sandgren\, Karolinska Institutet\nJohanna Sandgren\, PhD\, is Director of the Swedish Childhood Tumour Biobank at Karolinska Institutet and Karolinska University Hospital in Stockholm\, Sweden. She serves on the coordinating group of Genomic Medicine Sweden Childhood Cancer and the operational leadership group of the BrainChild initiative led by the Swedish Childhood Cancer Fund. She also currently contributes to the reference group for implementation of a digital biobank application system developed by Biobank Sverige. Dr. Sandgren earned her PhD in Cancer Genomics from Uppsala University and has more than 15 years of experience in the area of pediatric cancer research. The focus now\, and for almost 10 years\, is on facilitate the advancing of childhood cancer research\, and care\, through the research infrastructure Swedish Childhood Tumour Biobank (Barntumörbanken). This by enabling controlled access to population-based collection of high-quality biospecimens\, harmonized OMICS and meta data\, as well as via collaborations and services that support both research and clinical studies. \n\n\n\n\nAndreas Josefsson\, Umeå University\nAndreas Josefsson\, MD\, PhD\, is Associate Professor and Senior Consultant in Urology at Umeå University and Norrland University Hospital. His research focuses on prostate cancer\, particularly high-risk and metastatic disease\, combining clinical studies with translational work on tumour biology and biomarkers. He is principal investigator and chair of SPRINTR (Swedish PRecision medicine Initiative for Novel Treatments and Research)\, a national prospective platform in which patients are enrolled in routine care\, with structured clinical data\, molecular profiling\, imaging\, digital pathology\, possibility for biobanking\, and linkage to national registries. SPRINTR started in prostate cancer\, includes all seven Swedish university hospitals and several more sites\, and serves as a study-ready population for translational research and clinical trials. The concept is now being extended to other cancer types. He is also a member of the steering groups of Umeå Comprehensive Cancer Center\, the National Prostate Cancer Register\, and the Scandinavian Prostate Cancer Group. \n\n\n\n\nScientific committee\n\n\n\n\n\n\n\nProject manager\n\n\n\nAnna Clareborn \n\n\n\nEvent Sponsors\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nYou may also be interested in\n\n\n\n\nSciLifeLab Science Summit URL:https://www.scilifelab.se/event/the-promise-initiative-accelerating-cancer-innovation/ LOCATION:Lecture Hall X\, University Main Building\, Uppsala\, Biskopsgatan 3\, Uppsala\, 75105\, Sweden CATEGORIES:Event ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2025/12/Promise-Sweden-Banner-scaled.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20261014T084500 DTEND;TZID=Europe/Stockholm:20261014T170000 DTSTAMP:20260911T060729Z CREATED:20251219T121224Z LAST-MODIFIED:20260911T060729Z UID:10001689-1791967500-1791997200@www.scilifelab.se SUMMARY:SciLifeLab Science Summit DESCRIPTION:The Annual Conference SciLifeLab Science Summit is a one-day symposium with a new topic each year. The 2026 topic is: \n\n\n\nCancer Research: Translating Life Science Discoveries to Clinical Breakthroughs\n\n\n\nFor more than a century\, Swedish cancer research has shaped the international scientific landscape\, driven by strong academic environments and a deep societal commitment to transforming discoveries into better treatments. From breakthroughs in cancer genomics and tumor biology to advances in immunology and angiogenesis\, researchers in Sweden continue to push the boundaries of life science and medicine. \n\n\n\nThe SciLifeLab Science Summit brings this legacy into the future by uniting world-leading cancer researchers with cutting-edge technologies across genomics\, proteomics\, imaging\, data science\, and beyond. The summit creates an inspiring forum where scientific excellence meets societal relevance—fostering collaboration\, showcasing groundbreaking research\, and highlighting how cancer research continues to reveal fundamental mechanisms of life while driving innovation with real-world impact. \n\n\n\nThe conference is free of charge. Fika\, lunch and Meet-the-speaker-mingle will be included (only) if you register before deadline on September 21. \n\n\n\nJoin us for a full day of inspiring Science! \n\n\n\nWelcome! \n\n\n\nScientific Committee\n\n\n\n\n\n\n\nProject leader: Erika Erkstam\, Operations Office\, SciLifeLab \n\n\n\nRegistration\n\n\n\nDeadline (for registration and posters): September 21 \n\n\n\nQuestions? If you have any inquiries regarding the event or your registration\, please contact events@scilifelab.se \n\n\n\nFor late registrations (after September 21)\, we cannot guarantee lunch\, coffee\, nor can we accommodate any allergies or dietary requirements. These will be subject to availability. We appreciate your understanding. \n\n\n\nRegister here\n\n\n\n\n\n\n\n\n\n\n\nSpeakers\n\n\n\n\nAngelica Loskog\, Uppsala University and Lokon Pharma\n\n\n\nAnna Martner\, University of Gothenburg\, Sweden\n\n\n\nAri Molofsky\, University of California\, San Francisco\, US\n\n\n\nBernd Bodenmiller\, University of Zurich and ETH Zurich\, Switzerland\n\n\n\nGabriele Bergers\, VIB-KU Leuven Center for Cancer Biology\, Belgium\n\n\n\nGunilla Edblad\, Uppsala University and Uppsala University Hospital\n\n\n\nGöran B. Jönsson\, Lund University\n\n\n\nIñaki Martin-Subero\, ICREA Research Professor at IDIBAPS\, Barcelona\, Spain\n\n\n\nThoas Fioretos\, Lund University\n\n\n\n\nProf. Angelica Loskog\nUppsala University\, Sweden and Lokon Pharma. \n\n\n\nTitle: Evoking Tumor Immunity in Immune-Resistant Cancers \n\n\n\nAbstract: \n\n\n\nGrauers Wiktorin H1\, Lövgren T1\, Wenthe J1\, Ritter A1\, Calandegary A1\, Ekström Ryden V\,1\,2 Hahn A1\,2\, Hamid O3\, Gustafsson Liljefors M4\, Musher BL5\, Brenner MK5\, Ullenhag G1\,2\, Loskog A1\,6. \n\n\n\n1Uppsala University\, Uppsala\, Sweden \n\n\n\n2Uppsala University Hospital\, Uppsala\, Sweden \n\n\n\n3The Angeles Clinic and Research Institute\, A Cedars Sinai Affiliate\, Los Angeles\, CA\, USA \n\n\n\n4Karolinska Hospital\, Huddinge\, Sweden \n\n\n\n4Baylor College of Medicine\, Houston\, TX\, USA \n\n\n\n6Lokon Pharma AB\, Uppsala\, Sweden \n\n\n\nImmunotherapy for cancer is a cornerstone of cancer treatment but despite the initial success\, many patients are either primary resistant or develop resistance during treatment. By engineering the tumor microenvironment using and oncolytic adenoviral gene vector encoding TMZ-CD40L and 4-1BBL (LOAd703)\, we aim to rewire the immunosuppressive state in the patients to drive anti-tumor immune responses allowing for continued immune checkpoint inhibitor (ICI) treatment of refractor patients and/or ICI treatment of indications previously not responding to ICI. LOAd703 plus ICI have been tested in melanoma patients (n=24) refractory to one or several lines of prior ICI\, and in pancreatic cancer patients (LOAd703 +standard chemotherapy\, n=21; LOAd703 + ICI + standard chemotherapy\, n=24) who are commonly not responding to ICI. In these Phase I/II clinical trials blood and biopsies were analyzed for the initiation of immune responses locally in the tumor microenvironment as well as systemically in blood. \n\n\n\nThe treatment was well tolerated with common adverse events related to chemotherapy (pancreatic cancer) or ICI (melanoma and pancreatic cancer). LOAd703 attributed adverse events included fever\, chills\, and cytokine release syndrome\, mostly grade 1 or 2. Both in melanoma and pancreatic cancer\, LOAd703 promoted a typical Th1 type of immune response post treatment initiation which was noted both in the tumor and in blood. Similarly\, tumor responses were noted in both indications as evaluated with Olink proteomics\, NanoString Technology\, and flow cytometry. In conclusion\, LOAd703 can be used together with chemotherapy and/or ICI treatment to rewire the immunosuppressive state in patients towards Th1 immunity and subsequently controlling tumor growth in patients. \n\n\n\n \n\n\n\n\nProf. Anna Martner\nUniversity of Gothenburg\, Sweden. \n\n\n\nTitle: NOX2-derived ROS as drivers of metastatic progression \n\n\n\nBiosketch: Anna Martner is a group leader at the Sahlgrenska Center for Cancer Research\, University of Gothenburg. Her research focuses on myeloid cell-mediated immunosuppression\, NOX2-derived ROS\, tumor cell plasticity\, and metastasis. She trained with Professors Kristoffer Hellstrand and Dmitry Gabrilovich and spent a 2019 sabbatical in Professor Robert Weinberg’s laboratory at MIT studying EMT. \n\n\n\nAbstract: The efficacy of cancer immunotherapy depends on the balance between anti-tumor effector cells\, including natural killer (NK) cells and T cells\, and mechanisms of tumor-associated immunosuppression. Inflammatory myeloid cells\, including myeloid-derived suppressor cells (MDSCs)\, contribute to immune evasion through several mechanisms\, among them the production of reactive oxygen species (ROS) by NOX2. \n\n\n\nOur group investigates the role of NOX2-derived ROS in cancer-associated immunosuppression and metastasis\, and the potential of targeting this pathway therapeutically. We have shown that genetic or pharmacological inhibition of NOX2 promotes NK cell-mediated clearance of metastatic tumor cells and enhances the efficacy of immune checkpoint blockade (Aydin et al.\, Cancer Immunol Res\, 2017; Grauers Wiktorin et al.\, Cancer Immunol Immunother\, 2019). We also found that surgical stress aggravates NOX2-dependent immunosuppression and metastatic progression\, effects that can be counteracted by NOX2 inhibition (Grauers Wiktorin et al.\, Cancer Res Commun\, 2024). \n\n\n\nMore recently\, we found that myeloid cell-derived NOX2-generated ROS can act directly on tumor cells. These ROS induce epigenetic changes that activate epithelial-to-mesenchymal transition (EMT) programs and promote metastasis (Kaya et al.\, PNAS\, 2026). Thus\, NOX2-derived ROS may promote metastatic progression both by suppressing anti-tumor immunity and by enhancing tumor cell plasticity. \n\n\n\nHistamine dihydrochloride (HDC)\, which inhibits NOX2-dependent ROS formation\, is approved in the EU for relapse prevention in acute myeloid leukemia. In an ongoing clinical trial at the Sahlgrenska University Hospital\, we are investigating HDC in combination with IL-2 in patients undergoing surgery for pancreatic cancer\, with the aim of reducing perioperative immunosuppression and metastatic risk. \n\n\n\n\nProf. Ari Molofsky\nUniversity of California\, San Francisco \n\n\n\nTitle: Fibroblast – Immune niches in health and disease. \n\n\n\nBiosketch: Ari Molofsky received a BS with highest honors from the University of Texas at Austin and an MD/PhD with research distinction from the University of Michigan in Ann Arbor. Dr. Molofsky completed residency and fellowship in Clinical Pathology/Hematopathology and now leads a tissue immunology-focused research group in the Department of Laboratory Medicine at UCSF. Dr. Molofsky’s research goals are to understand the regulation and function of tissue-resident immune cells to define novel pathways that can be targeted across diverse human diseases. These tissue-resident immune cells are early organizers of tissue remodeling and first responders during tissue damage and infection\, positioning them as key mediators of tissue health and disease. The Molofsky lab has defined a stromal-immune niche surrounding larger vessels and other border structures in multiple tissues\, including the lungs and brain. They are using 3D quantitative microscopy\, single-cell and spatial transcriptomics\, and cytokine reporters/manipulators to dissect these critical immune-microenvironment interactions\, with a particular focus on bidirectional interactions with fibroblasts. Dr. Molofsky has published papers spanning microbial pathogenesis\, tissue-resident immunity\, and local immune niches. Dr. Molofsky is actively involved in trainee education and teaching and leads the UCSF medical school immunology course. Dr. Molofsky routinely serves as an ad hoc reviewer for multiple journals and is a standing member of the NIH Innate Immunity study section. \n\n\n\nAbstract: \n\n\n\n\nProf. Bernd Bodenmiller\nUniversity of Zurich and ETH Zurich\, Switzerland \n\n\n\nTitle: Highly multiplexed imaging of tissues with subcellular resolution by imaging mass cytometry \n\n\n\nBiosketch: Bernd Bodenmiller is a quantitative biologist who develops novel experimental and computational approaches for the quantitative analysis of tumor ecosystems to improve our understanding of the mechanisms of tumor development for the benefit of patients. He is the founding director of the Department of Quantitative Biomedicine (DQBM) at the University of Zurich\, which fosters research and education at the interface of biomedical research\, biotechnology\, and computational biology to guide development of next-generation precision medicine. Prof. Bodenmiller obtained his PhD in the group of Ruedi Aebersold at ETH Zürich. For his postdoctoral training\, he joined the laboratory of Garry P. Nolan at Stanford University. In 2012\, he became a group leader and in 2013 an SNF/ERC assistant professor at the University of Zürich. In 2019\, he was tenured and became the founding director of the DQBM. In October 2020 Prof. Bodenmiller has been appointed as Dual Professor for Quantitative Biomedicine at the UZH and at ETH Zurich. His group pioneered the development of imaging mass cytometry\, an approach that enables simultaneously imaging of over 40 proteins and transcripts in tumor tissues (Nat. Methods\, 2014; Cell Systems\, 2017; Nature 2020) and the histoCAT software toolbox (Nat. Methods\, 2017). His groups applies these methods to unravel how cells in the tumor ecosystem drive cancer development to identify mechanisms that might be exploited for therapeutic targeting (Nat. Biotechnology\, 2017\, Cell\, 2017; Cell\, 2019). \n\n\n\nAbstract: Cancer is a tissue disease. Heterogeneous cancer cells and normal stromal and immune cells form a dynamic ecosystem that evolves to support tumor expansion and ultimately tumor spread. The complexity of this dynamic system is the main obstacle in our attempts to treat and heal the disease. The study of the tumor ecosystem and its cell-to-cell communications is thus essential to enable an understanding of tumor biology\, to define new biomarkers to improve patient care\, and ultimately to identify new therapeutic routs and targets. \n\n\n\nTo study and understand the workings of the tumor ecosystem\, highly multiplexed image information of tumor tissues is essential. Such multiplexed images will reveal which cell types are present in a tumor\, their functional state\, and which cell-cell interactions are present. To enable multiplexed tissue imaging\, we developed imaging mass cytometry (IMC). IMC is a novel imaging modality that uses metal isotopes of defined mass as reporters and currently allows to visualize over 50 antibodies and DNA probes simultaneously on tissues with subcellular resolution. In the near future\, we expect that over 100 markers can be visualized. We applied IMC for the analysis of breast cancer samples in a quantitative manner. To extract biological meaningful data and potential biomarkers from this dataset\, we developed a novel computational pipeline called histoCAT geared for the interactive and automated analysis of large scale\, highly multiplexed tissues image datasets. Our analysis reveals a surprising level of inter and intra-tumor heterogeneity and identify new diversity within known human breast cancer subtypes as well as a variety of stromal cell types that interact with them.In summary\, our results show that IMC provides targeted\, high-dimensional analysis of cell type\, cell state and cell-to-cell interactions within the TME at subcellular resolution. Spatial relationships of complex cell states of cellular assemblies can be inferred and potentially used as biomarkers. We envision that IMC will enable a systems biology approach to understand and diagnose disease and to guide treatment. \n\n\n\n\nProf. Gabriele Bergers\nVIB-KU Leuven Center for Cancer Biology\, Belgium \n\n\n\nTitle: A vascular perspective on immunity in cancer and inflammation \n\n\n\nBiosketch: Dr. Gabriele Bergers is a Professor of Oncology at the University of Leuven and a Principal Investigator at the Vlaams Instituut Voor Biotechnologie (VIB)-Center for Cancer Biology in Leuven since 2016. Prior\, she followed the faculty rank at the University of California\, San Francisco\, and was a Professor in the Department of Neurological Surgery and a PI in the Brain Tumor Research Center (BTRC) at the Helen Diller Family Comprehensive Cancer Center at the University of California\, San Francisco until 2016. \n\n\n\nThe overall research interest of her group relates to the tumor vasculature\, which entails an integral and critical component of the tumor microenvironment and closely interacts with distinct cell constituents of the heterogeneous tumor community. Such crosstalk is pivotal not only for the genesis and progression of a tumor but also for the tumor’s ability to resist therapeutic elimination. \n\n\n\nOver the last years\, her group has made seminal discoveries in the heterogenous crosstalk of the vascular immune axis and identified several intimate regulatory mechanisms between angiogenesis and immunosuppression that provide novel target possibilities to enhance the effects of cancer therapy by modulating the tumor vascular system and its communication with immune cells; among those\, to induce high endothelial venules and subsequent tertiary lymphoid structures\, with the overarching goal to sensitize and enhance an immune response in cancer patients to thwart tumors and metastases and invigorate tissue homeostasis. \n\n\n\nFor her research\, Dr. Bergers has received several awards\, including the Sidney Kimmel\, the Sandler Opportunity\, UCSF Breakthrough Biomedical Research\, and the Judah Folkman Award. She has acted as an external advisory board member for a number of universities and pharmaceutical companies; most recently for Mestag Therapeutics. Dr. Bergers was the co-director of the U54 Tumor microenvironment Brain Tumor Center at UCSF until 2016. She was  a Scientific co-founder of Oncurious. \n\n\n\nAbstract: The vasculature is a critical gatekeeper of tissue immunity\, determining which cells can enter or exit a tissue. During infection\, specialized endothelial cells known as high endothelial venules (HEVs)become activated to promote lymphocyte entry into lymph nodes\, enabling efficient immune priming against pathogens. In cancer\, however\, the vascular system is frequently reprogrammed to suppress immunity. Tumor endothelial cells can form barriers that limit lymphocyte infiltration\, contributing to immune-cold or immune-desert tumors. At the same time\, tumor cells actively remodel HEVs in tumor-draining lymph nodes\, altering their phenotype to facilitate tumor cell intravasation and systemic dissemination. \n\n\n\nRecent mechanistic insights into HEV regulation reveal that the vascular system can also be therapeutically reprogrammed. Induction of intratumoral HEVs can promote lymphocyte recruitment and the formation of tertiary lymphoid structures (TLS)\, which are associated with stronger anti-tumor immunity and improved clinical outcomes. In contrast\, chronic inflammatory diseases such as psoriasis also display HEV expansion accompanied by persistent T-cell aggregates\, where excessive lymphocyte influx may exacerbate pathology. \n\n\n\nHere\, I will discuss HEVs as central vascular regulators of local and systemic immune responses across cancer and chronic inflammation. I will highlight emerging strategies to modulate the vascular axis to either enhance anti-tumor immunity or dampen pathological inflammation\, positioning HEVs as promising therapeutic targets for restoring tissue immune homeostasis. \n\n\n\n\nProf. Gunilla Enblad\nUppsala University and Uppsala University Hospital \n\n\n\nTitle: CAR T-cells a powerful new immunotherapy \n\n\n\nBiosketch: Gunilla Enblad is professor of oncology at Uppsala university Hospital and Uppsala University and senior consultant in oncology. Her main research interests are lymphomas and CAR T-cells. She was PI for the first two academic CAR T-cell trials in Uppsala\, started already 2014 which was first in Europe. She is now PI for a third academic CAR T-cell trials for lymphomas. She is the chairman of the Swedish CAR T-cell group and co-chairman of SWECARNET\, a collaborative group on CAR T-cells. She is currently performing clinical and translational research on lymphomas and CAR T-cells. \n\n\n\nAbstract: Chimeric antigen receptor (CAR) T-cell therapy has emerged as a promising treatment for relapsed and refractory malignancies and autoimmune disease. CAR T-cells are autologous T lymphocytes genetically modified to express a synthetic receptor targeting a surface antigen on the selected cells i.e. tumor cell or B-cell.. Most clinically approved CAR T-cell products target CD19\, which is widely expressed on B-cell lymphomas and leukemias. Following ex vivo genetic modification and expansion\, the cells are reinfused into the patient to mediate targeted anti-tumor activity. \n\n\n\nClinical studies have demonstrated remarkable efficacy\, with many patients achieving durable remissions and potential cures despite having exhausted conventional treatment options. Uppsala University Hospital pioneered CAR T-cell therapy in Europe\, initiating academic studies in 2014 and contributing to the implementation of CAR T-cells as standard of care in Sweden since 2019. Current research focuses on improving efficacy while reducing treatment-related toxicities\, including cytokine release syndrome\, neurotoxicity\, and immune effector cell-associated hematotoxicity. \n\n\n\nA novel academic phase I study\, CARMA\, evaluates an in-house produced CD20-targeting CAR T-cell armed with a neutrophil activating protein (NAP) derived from Helicobacter pylori. Preliminary results are highly encouraging\, with complete metabolic remissions observed in many evaluable patients and only mild adverse effects. Ongoing translational studies aim to identify biomarkers of response and resistance\, ultimately supporting the development of safer and more effective CAR T-cell therapies. \n\n\n\n\nProf. Göran Jönsson\nLund University \n\n\n\nTitle: Exploring the role of the anti-tumor immune response in tumor initiation and therapy response in melanoma \n\n\n\nBiosketch: Göran Jönsson is a professor in molecular oncology at Lund University. His research has for many years been based on strong collaboration between basic- and clinician scientists in truly translational projects. Considering this and his background in state-of-the art genomic technologies and applying that on human melanoma tissue puts him in a perfect position to conduct research that will generate groundbreaking findings. This is further substantiated by the group’s publication in Nature (2020). Göran is a faculty member of ESMO (European Society of Medical Oncology) and have an extensive international network. He is frequently invited to large international meetings and acts as a reviewer to several funding agencies and high-impact journals such as Nature. Göran has also been the recipient of Young and Senior Investigator Awards from the Swedish Cancer Society and more recently was awarded with the Göran Gustafsson prize in medicine 2022 from the Royal Swedish Academy of Sciences and Cancer Researcher of the year (2023) from the Swedish Cancer Society. \n\n\n\nAbstract: \n\n\n\n \n\n\n\n\nProf. Iñaki Martin-Subero\nICREA Research Professor at IDIBAPS\, Barcelona\, Spain \n\n\n\nTitle: Epigenetic memory in chronic lymphocytic leukemia: decoding the past predicts the future \n\n\n\nBiosketch: In 2001\, I obtained my PhD in Biochemistry from the University of Navarra on genetics of lymphoid neoplasms under the supervision of Prof. Maria J Calasanz and co-supervision of Prof. Reiner Siebert from the Christian-Albrechts University of Kiel. After that\, I continued my studies on lymphoma genetics as postdoctoral fellow with Prof. Siebert. In 2005\, I became interested in the field of epigenomics and in 2009 I came back to Spain. After a short stay at the IDIBELL\, I went to the UB/IDIBAPS to start my career as independent researcher embedded in the group of Prof. Elias Campo. In 2016\, I was appointed Junior Leader of the Biomedical Epigenomics group at the IDIBAPS and from November 2018 I am ICREA Research Professor at the IDIBAPS. I also have an appointment as associate professor at the UB. Our group is interested in the role of epigenetics in the origin\, evolution and clinical manifestations of lymphoid tumors. \n\n\n\nAbstract: Chronic lymphocytic leukemia (CLL) is the most frequent leukemia in the Western world. Its clinical behavior is extremely variable\, ranging from cases that regress spontaneously without treatment to cases that transform to aggressive lymphomas with short median survival\, a condition called Richter transformation. Such clinical heterogeneity is partially associated with genetic features\, although predicting the future clinical evolution of CLL patients is still challenging. During the last decade\, we have also been investigating the CLL epigenome. We have observed that CLL cells carry DNA methylation imprints of their cellular origin allowing the distinction of three clinical subtypes derived from B cells at different maturation stages. Additionally\, DNA methylation changes in late replicating regions accumulate as cancer cells divide\, allowing the development of a mitotic clock that is able to trace the proliferative history of cancer cells. Furthermore\, using CpG sites with fluctuating methylation\, it is now possible to decode the evolutionary dynamics of CLL development. These aspects of epigenetic memory are strongly associated with disease progression. Studying the transition from CLL to Richter transformation from a multiomics perspective\, we detected that progression was accompanied by the expected increase in complexity of several molecular layers. However\, a detailed genomics and transcriptomics examination at the single cell level revealed that the Richter-associated subclone was present in minute amounts already at the time of diagnosis\, up to two decades before transformation. Overall\, these studies and additional unpublished data presented in the meeting\, indicate that molecular imprints of the past are useful markers to estimate the future clinical behavior of the patients. \n\n\n\n\nProf. Thoas Fioretos\nLund University \n\n\n\nTitle: From Genomic Discoveries to Better Diagnostics and Therapies in Acute Leukemia \n\n\n\nBiosketch: Thoas Fioretos\, MD\, PhD\, is Professor of Clinical Genetics at Lund University and Senior Consultant at Skåne University Hospital. His research focuses on the molecular basis of acute leukemia and its translation into improved diagnostics and targeted therapies. His group applies genomic and single-cell approaches to define cell states\, stem-cell properties\, immune-evasion mechanisms and cell-surface targets. The group was among the first to establish IL1RAP as a therapeutic target on leukemia stem cells and recently identified SLAMF6 as an immune checkpoint in acute myeloid leukemia. These discoveries have supported antibody-based therapies\, including an investigator-initiated trial evaluating an IL1RAP-targeting antibody in AML and high-risk MDS at MD Anderson Cancer Center. Fioretos is a Wallenberg Clinical Scholar\, Platform Scientific Director of Clinical Genomics Lund at SciLifeLab and a founding member of Genomic Medicine Sweden. He is a member of the Royal Swedish Academy of Sciences and currently chairs its Class for Medical Sciences. \n\n\n\nAbstract: \n\n\n\n \n\n\n\n \n\n\n\n\nProgram\n\n\n\n08:45Registration and poster hangingPlease leave large bags and outerwear in the staffed Cloakroom09:00Doors open. Be seated at 09:1509:15Welcome by SciLifeLab Director Jan Ellenberg09:35Session 1: Immune Niches in CancerModerator: Anna DimbergA vascular perspective on immunity in cancer and inflammationGabriele Bergers\, VIB-KU Leuven Center for Cancer Biology\, BelgiumExploring the role of the anti-tumor immune response in tumor initiation and therapy response in melanomaGöran Jönsson\, Lund University\, SwedenFlash Talks10:45Coffee and Poster session (odd numbers)11:25Session 2: Tumor Microenvironment and Clinical TranslationModerator: Carina StrellFibroblast – Immune niches in health and diseaseAri Molofsky\, University of California\, San Francisco (UCSF)\, USEvoking Tumor Immunity in Immune-Resistant CancersAngelica Loskog\, Uppsala University\, Sweden and Lokon PharmaCAR T-cells: a powerful new immunotherapyGunilla Enblad\, Uppsala University and Uppsala University Hospital\, Sweden12:45Lunch13:45Session 3: Precision OncologyModerator: Jessica Nordlund & Panagiotis BaliakasEpigenetic memory in chronic lymphocytic leukemia: decoding the past predicts the futureIñaki Martin-Subero\, IDIBAPS\, SpainFrom Genomic Discoveries to Better Diagnostics and Therapies in Acute LeukemiaThoas Fioretos\, Lund University\, Sweden14:45Roundtable discussion: What is needed to translate Swedish cancer discoveries into clinical implementation?Moderator: Thuy TranPanelists: Gunilla Enblad\, Thoas Fioretos\, Maréne Landström\, Angelica Loskog\, Kristian Sandberg.Flash Talks15:15Coffee and Poster session (even numbers)15:55Session 4: Tumor Ecosystems and Spatial BiologyModerator: Aristidis MoustakasHighly multiplexed imaging of tissues with subcellular resolution by imaging mass cytometryBernd Bodenmiller\, University of Zurich and ETH Zurich\, SwitzerlandNOX2-derived ROS as drivers of metastatic progressionAnna Martner\, University of Gothenburg\, Sweden16:50Best Poster Award and Closing wordJan Ellenberg\, Director\, SciLifeLabPoster Jury of SciLifeLab and DDLS Fellows17:00Meet-the-speaker and network mingle with snacks and beverages18:15End of SciLifeLab Science Summit\n\n\n\nProgram Science Summit 2026Download\n\n\n\nPoster session\n\n\n\nEveryone\, especially junior (PhD and postdoc) researchers are encouraged to participate with poster presentations and have the opportunity to win the Best Poster Award. \n\n\n\nDetails about the Poster session\nPoster Presentation Guidelines \n\n\n\nPoster Format \n\n\n\nThe poster boards are 103 cm wide and 143 cm high. \n\n\n\nMount your poster \n\n\n\nThe venue will be open from 8:45 AM. Please proceed to the 6th floor and hang your poster at your designated number. A numbered poster list will be provided closer to the event date. \n\n\n\nPoster sessions \n\n\n\nPoster Session I: During the morning coffee break\, presenters of posters with odd numbers (1\, 3\, 5\, 7…) should be present by their posters. \n\n\n\nPoster Session II: During the afternoon break\, presenters of posters with even numbers (2\, 4\, 6\, 8…) should be present by their posters. \n\n\n\nBest Poster Award \n\n\n\nAll poster presenters should attend the Best Poster Award ceremony at the end of the conference\, where the Best Poster Award will be announced. The Poster Jury will read the abstracts and evaluate the posters throughout the day based on (a) Quality of Science (b) Design (c) Capacity to explain the work. The Poster Jury will select the 2026 Science Summit Best Poster and award the winner a 5\,000 SEK Travel Grant (conditions apply). \n\n\n\nFlash Talks (5-min research pitch) selected from Abstracts. \n\n\n\nThe abstracts will be published on the event website and used to select Flash Talks (5-min research pitch).  \n\n\n\nDismount of posters \n\n\n\nPlease remove your poster immediately after the closing session at 5:00 PM. Poster screens will be collected at 5:30 PM\, and any remaining posters will be discarded. \n\n\n\n\nBest Poster Award\n\n\n\nThe Poster jury\, consisting of SciLifeLab Fellows\, will nominate the Science Summit 2026 Best Poster and award the winner a 5 000 SEK Travel Grant. \n\n\n\nSpread the word – download the flyer\n\n\n\nDigital sign_SS26_qrDownload\n\n\n\n\n\n\n\nPractical information\n\n\n\nTravel to Uppsala\n\n\n\nThe Venue\, Uppsala Konsert & Kongress (UKK) is next to the Train station. MAP here! Travel centres\, bus stops\, parking and hotels are all located within walking distance from Uppsala Konsert & Kongress. Several train and bus lines connect Uppsala to the rest of the country and the region\, and Arlanda Airport is only 18 minutes by train\, Stockholm Central station is approx. 30 minutes by train. \n\n\n\nUppland public transport (UL) timetables and information: www.ul.seStockholm public transport (SL) timetables and information: www.sl.se SJ timestables and information: www.sj.se \n\n\n\nGood to know\, travelling to Uppsala. \n\n\n\nParking\n\n\n\nThe nearest parking garage is Centralgaraget. There is also parking available in Kvarnens parking garage\, Svava\, S:t Per Gallerians garage\, Österplan\, and several other locations in central Uppsala. For more information about parking in the area\, please visit Uppsala Parkering. \n\n\n\nHotels in Uppsala\n\n\n\nFind suggestions for accommodation in Uppsala here \n\n\n\n\nImproved event experience: Introducing the Lyyti Event app \n\n\n\nThis event uses Lyyti for registration. Lyyti has launched the Lyyti Event app\, where you can find your Lyyti registration\, confirmation\, and ticket. You can also edit your information until the registration deadline. \n\n\n\nTo get started\, download “Lyyti Event” and sign up with the same email address you normally use for event registrations. The app only displays events associated with the email address used to create your account. \n\n\n\nIf you register for events using multiple email addresses\, your registrations will be split across separate app accounts. For the best experience\, please use one consistent email address for all Lyyti registrations. We hope this new functionality makes it easier for you to manage your participation. \n\n\n\n\nYou may also be interested in:\n\n\n\n\nThe PROMISE Initiative: Accelerating Cancer Innovation URL:https://www.scilifelab.se/event/scilifelab-science-summit-2/ LOCATION:Uppsala Konsert & Kongress (UKK)\, Vaksala torg 1\, Uppsala\, 753 31\, Sweden CATEGORIES:Event ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2025/12/Hemsidan_feature-image-kopiera.jpg ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20261015T120000 DTEND;TZID=Europe/Stockholm:20261015T130000 DTSTAMP:20260819T123245Z CREATED:20260819T121327Z LAST-MODIFIED:20260819T123245Z UID:10001867-1792065600-1792069200@www.scilifelab.se SUMMARY:Campus Solna Seminar Series: Paula Otero Garcia & Riccardo Mosca DESCRIPTION:Welcome to join the Campus Solna Seminar Series – an initiative to promote the fantastic science ongoing at Campus Solna and hopefully forge more internal communication and collaboration between within Campus Solna. The format consists of two 20 min talks (One speaker from the Alpha-building and one from the Gamma-building respectively)\, with an additional 5 min of questions. Presentation of ongoing (unpublished) projects is strongly encouraged. \n\n\n\nThe seminars are held Thursdays 12:00-13:00. You can bring your lunch to the seminar. \n\n\n\nPhD students that are attending the Campus Solna Seminar lectures will have the opportunity to gain credits. For the syllabus and instructions on how to obtain these credits\, read this document. Please contact your own department at your host University to confirm.See here the full schedule for this semester. \n\n\n\nThis week:\n\n\n\n\n\n\nPaula Otero Garcia\n\n\n\nAnders Andersson – alpha \n\n\n\n \n\n\n\n\n\nRiccardo Mosca\n\n\n\nClaudia Kutter – gamma 5 \n\n\n\n \n\n\n\n\n\n\nThis seminar series is organized by the PhD & Postdoc Council. For more information about the Council and other events check our page. URL:https://www.scilifelab.se/event/campus-solna-seminar-series-15oct/ LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden CATEGORIES:Community ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2022/09/IMG_20221103_124630107_HDR-scaled.jpg ORGANIZER;CN="SciLifeLab Solna PhD & Postdoc Council":MAILTO:phd-council@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20261015T150000 DTEND;TZID=Europe/Stockholm:20261015T163000 DTSTAMP:20260916T084846Z CREATED:20260916T084845Z LAST-MODIFIED:20260916T084846Z UID:10001895-1792076400-1792081800@www.scilifelab.se SUMMARY:Power Dynamics in Academia DESCRIPTION:Diversity\, Equity & Inclusion at SciLifeLab (DEIS) invites all members of the SciLifeLab community to a moderated discussion and fika with an expert speaker occupying a unique perspective on research and conduct in the life sciences.This seminar explores how power operates within academic and research spaces\, focusing on the ways it is exercised\, sustained\, and reproduced. It critiques hierarchical structures and conventional success metrics\, which are often shaped by patriarchal and neoliberal norms\, and considers their effects on academic relationships and research practices. Drawing on the work of thinkers such as Paulo Freire\, the presentation introduces alternative frameworks and practical strategies to challenge entrenched power relations and to cultivate more inclusive\, equitable\, and supportive research environments\, and is followed by discussion with the community. \n\n\n\n\n\n\n\n\n\n\n\n\n\ndei-scilifelab@scilifelab.se URL:https://www.scilifelab.se/event/power-dynamics-in-academia/ LOCATION:Gamma 2 Lunchroom\, SciLifeLab\, Tomtebodavägen 23\, Solna\, Sweden CATEGORIES:Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20261019T140000 DTEND;TZID=Europe/Stockholm:20261019T163000 DTSTAMP:20260904T114410Z CREATED:20260903T085025Z LAST-MODIFIED:20260904T114410Z UID:10001885-1792418400-1792427400@www.scilifelab.se SUMMARY:Sweden AI Factory for Life Science DESCRIPTION:Register here\n\n\n\nGranitsalen\n\n\n\n\nMeet the experts from the new Sweden AI Factory’s life science team​ \n\n\n\nTackle complex data analysis challenges and accelerate your projects with AI​ \n\n\n\nExplore adoption of state-of-the-art AI techniques while avoiding common pitfalls​ \n\n\n\nGet free access to powerful GPUs​ \n\n\n\nInvited speakers with user stories​ \n\n\n\nMathieu Coincon\, Facility Manager at SciLifeLab’s Cryo-EM facility\, Stockholm University​ \n\n\n\nPeter Larsson\, Professor in Molecular Neurophysiology\, Linköping University​ \n\n\n\nQ&A session​ \n\n\n\nFull program and more information about the content will soon be added here. \n\n\n\nOrganized by SciLifeLab Linköping and Sweden AI Factory \n\n\n\nIf you have any questions\, please contact josefine.sandstrom@liu.se URL:https://www.scilifelab.se/event/ai-factory-for-life-science/ CATEGORIES:Event ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2026/09/A-factory-event-picture-2026-10-14.jpeg ORGANIZER;CN="SciLifeLab Link%C3%B6ping":MAILTO:linkoping@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20261022T080000 DTEND;TZID=Europe/Stockholm:20261023T170000 DTSTAMP:20260604T095159Z CREATED:20260604T094520Z LAST-MODIFIED:20260604T095159Z UID:10001845-1792656000-1792774800@www.scilifelab.se SUMMARY:Immunity by Design – In vivo Immune Cell Engineering Conference DESCRIPTION:Immunity By Design brings together scientists\, clinicians\, and biotech leaders shaping the future of immune cell engineering and immunotherapy. The event will serve as a platform to foster new collaborations across academia\, industry\, and healthcare\, while engaging early career scientists in this fast-moving field. Designed to strengthen Swedish and international research ecosystems\, Immunity By Design will feature breakthroughs in immune engineering\, immune cell therapy\, synthetic immunology\, gene delivery technologies\, and translational research. As in vivo immune engineering rapidly emerges as a transformative cell therapy\, this conference is an exciting opportunity to discuss key findings and ideas for modulating immune responses directly within patients.ORGANIZER: Filipe Pereira\, Lund University; William Nyberg\, Karolinska Institutet; Alexandra Teleki\, Uppsala University \n\n\n\nRead more and Register URL:https://www.scilifelab.se/event/immunity-by-design-in-vivo-immune-cell-engineering-conference/ LOCATION:Palestra et Odeum\, Paradisgatan 4\, 223 50 Lund\, Sweden\, Paradisgatan 4\, Lund\, 223 50\, Sweden CATEGORIES:Event ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2026/06/Immunity-by-Design_SciLifeLab-flyer_June26.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20261022T084500 DTEND;TZID=Europe/Stockholm:20261022T180000 DTSTAMP:20260907T064953Z CREATED:20260615T184950Z LAST-MODIFIED:20260907T064953Z UID:10001848-1792658700-1792692000@www.scilifelab.se SUMMARY:CBCS 15th Anniversary Symposium DESCRIPTION:Celebrating 15 years of advancing chemical biology\, drug discovery\, and translational science through cutting-edge technologies and collaborative research. \n\n\n\nDate: October 22\, 2026 \n\n\n\nTime: 08:45-18:00 \n\n\n\nVenue: The Main Auditorium (Stora hörsalen)\, Swedish Museum of Natural History\, Frescativägen 40\, Stockholm \n\n\n\n \n\n\n\nProgram\n\n\n\n15th Anniversary Program_20260603Download\n\n\n\nRegistration\n\n\n\nThe symposium is free of charge. A no-show fee of SEK 2\,000 will apply to registered participants who fail to attend without prior cancellation. Remember to cancel if you can´t come. \n\n\n\nRegister here\n\n\n\nORGANIZER: CBCS \n\n\n\nCONTACT FOR QUESTIONS: Per Moberg\, per.moberg@ki.se URL:https://www.scilifelab.se/event/cbcs-15th-anniversary-symposium/ LOCATION:Swedish Museum of Natural History\, Frescativägen 40\, Stockholm\, Stockholm\, 114 18\, Sweden CATEGORIES:Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20261022T120000 DTEND;TZID=Europe/Stockholm:20261022T130000 DTSTAMP:20260819T123235Z CREATED:20260819T121502Z LAST-MODIFIED:20260819T123235Z UID:10001868-1792670400-1792674000@www.scilifelab.se SUMMARY:Campus Solna Seminar Series: Vsevolod Viliuga & Nina Trubanová DESCRIPTION:Welcome to join the Campus Solna Seminar Series – an initiative to promote the fantastic science ongoing at Campus Solna and hopefully forge more internal communication and collaboration between within Campus Solna. The format consists of two 20 min talks (One speaker from the Alpha-building and one from the Gamma-building respectively)\, with an additional 5 min of questions. Presentation of ongoing (unpublished) projects is strongly encouraged. \n\n\n\nThe seminars are held Thursdays 12:00-13:00. You can bring your lunch to the seminar. \n\n\n\nPhD students that are attending the Campus Solna Seminar lectures will have the opportunity to gain credits. For the syllabus and instructions on how to obtain these credits\, read this document. Please contact your own department at your host University to confirm.See here the full schedule for this semester. \n\n\n\nThis week:\n\n\n\n\n\n\nVsevolod Viliuga\n\n\n\nArne Elofsson – alpha \n\n\n\n \n\n\n\n\n\nNina Trubanová\n\n\n\nMarc Friedländer – gamma 5 \n\n\n\n \n\n\n\n\n\n\nThis seminar series is organized by the PhD & Postdoc Council. For more information about the Council and other events check our page. URL:https://www.scilifelab.se/event/campus-solna-seminar-series-22oct/ LOCATION:Milkyway SciLifeLab Solna\, Tomtebodavägen 23\, Solna CATEGORIES:Community ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2022/12/IMG_4110-scaled.jpg ORGANIZER;CN="SciLifeLab Solna PhD & Postdoc Council":MAILTO:phd-council@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20261027T090000 DTEND;TZID=Europe/Stockholm:20261029T150000 DTSTAMP:20260915T075932Z CREATED:20260817T093051Z LAST-MODIFIED:20260915T075932Z UID:10001858-1793091600-1793286000@www.scilifelab.se SUMMARY:Exhibition in Navet at BMC\, Uppsala University DESCRIPTION:October 27-29\, between 09.00-15.00: Don’t miss the chance to discover the latest from the 33 top life science companies in Sweden and around the world.The entrance to Navet (BMC\, entrance C11) will be open between 09:00-15:00 for external visitors. URL:https://www.scilifelab.se/event/exhibition-in-navet-at-bmc-uppsala-university-4/ LOCATION:Navet\, SciLifeLab Uppsala\, SciLifeLab Uppsala\, BMC C11\, Husargatan 3\, Uppsala\, 75237\, Sweden CATEGORIES:Event ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2026/08/October_samling_Logos_digital-sign_hemsidan-1-scaled.jpg ORGANIZER;CN="SciLifeLab Navet":MAILTO:lokalbokning@scilifelab.uu.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20261027T110000 DTEND;TZID=Europe/Stockholm:20261027T120000 DTSTAMP:20260916T093614Z CREATED:20260916T093613Z LAST-MODIFIED:20260916T093614Z UID:10001893-1793098800-1793102400@www.scilifelab.se SUMMARY:When every hypothesis is published: AI and the exploitation of Open Science Assets DESCRIPTION: Open science has given us a shared public good\, in the form of publications and public datasets\, free to access and reuse by anyone. But AI can now generate\, test and write up hypotheses against those assets faster than our community can evaluate them. This seminar looks at what happens to open repositories when they become inputs to industrial-scale hypothesis generation. We will also provide case studies of outputs that can be generated in under an hour\, and examples of the impact on the literature (including the de facto banning of some open science resources altogether). It also asks what data stewards\, funders and publishers can realistically do about it. \n\n\n\nPresenters: \n\n\n\nMatt Spick Institute for People-Centred AI\, University of Surrey\, UK \n\n\n\nMatt Spick is a Lecturer in Health and Biomedical Data Analytics at the University of Surrey and a member of the Institute for People-Centred AI. His research focuses on AI\, research integrity\, Open Science and the detection of problematic scientific publishing. \n\n\n\n Danny Maupin School of Health Sciences\, University of Surrey\, UK \n\n\n\nDanny Maupin is a Research Fellow in Health Data Sciences at the University of Surrey. His research spans digital health\, AI and research integrity\, including how generative AI is changing research practices and the use of Open Science resources. \n\n\n\nThe session will conclude with an open Q&A\, providing an opportunity to ask questions and interact with presenters. \n\n\n\nMore Information\n\n\n\nThis event is part of the SciLifeLab Open Science seminar series\, an event series by the SciLifeLab Data Centre and NBIS joint Data Management team.The goal of the events in this seminar series is to provide interesting interactive seminars around topics related to Research Data Management and Open Science in general\, and to foster discussions around best practices. \n\n\n\nResearch Data Management (RDM) concerns the organization\, storage\, preservation\, and sharing of data that is collected and analyzed during a research project. Proper planning and management of research data will make project management easier and more efficient while projects are being performed. It also facilitates sharing and allows others to validate as well as reuse the data.Open Science is a set of principles and practices that aim to make scientific research from all fields accessible to everyone for the benefits of scientists and society as a whole. Open science is about making sure not only that scientific knowledge is accessible but also that the production of that knowledge itself is inclusive\, equitable and sustainable. \n\n\n\nThe events are open to everyone working at or affiliated with a Swedish research institute or university. We welcome all researchers\, educational professionals\, staff\, RDM professionals\, and others with an interest in life sciences\, from all university levels. The events are informal and inclusive\, so feel welcome to join and participate in our interesting discussions! \n\n\n\nThe events will be recorded and published openly after the seminars on the SciLifeLab YouTube channel. The slides will be made available at our SciLifeLab Data Repository.More information about SciLifeLab Data Centre and NBIS joint Open Science seminar series: https://www.scilifelab.se/data/scilifelab-data-management-seminar-series/ \n\n\n\nIf you have suggestions for topics or presentations\, please contact us at data-management@scilifelab.seFor more information or inquiries\, please contact us at  data-management@scilifelab.se URL:https://www.scilifelab.se/event/when-every-hypothesis-is-published-ai-and-the-exploitation-of-open-science-assets/ LOCATION:Online event via Zoom ORGANIZER;CN="Open Science Seminar Series":MAILTO:data-management@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20261028T083000 DTEND;TZID=Europe/Stockholm:20261030T170000 DTSTAMP:20260728T123422Z CREATED:20251204T090638Z LAST-MODIFIED:20260728T123422Z UID:10001678-1793176200-1793379600@www.scilifelab.se SUMMARY:Integrating Scales in Planetary Biology DESCRIPTION:Integrating Scales in Planetary Biology 2026 brings together researchers and stakeholders across disciplines to explore how biological processes — from cells to ecosystems — shape the resilience of life on a changing planet. \n\n\n\nThe conference is designed to foster cross-disciplinary collaboration\, connecting scientists with industry partners\, funders\, and policy-makers to translate knowledge into actionable solutions. \n\n\n\nLed by Planetary Biology at SciLifeLab\, this meeting builds on the momentum of the EMBO workshop “Integrating Cell and Planetary Scales to Address Climate Resilience” (Lisbon\, 2025) and aims to strengthen an emerging international community working at the intersection of molecular biology\, environmental science\, and planetary health. \n\n\n\nHighlights of the programme include:– Scientific talks across disciplines– Round table discussions on emerging research priorities– Pitch Slam session– Panels with funding and policy stakeholders– Dedicated time for networking and collaboration \n\n\n\nInvited speakers \n\n\n\n\nMargaret McFall-Ngai\, Carnegie Science\, US\n\n\n\nAlexandra Worden\, Marine Biological Laboratory\, US\n\n\n\nCorentin Bisot\, AMOLF Institute\, The Netherlands & EMBL\, Germany\n\n\n\nDetlev Arendt\, EMBL\, Germany\n\n\n\nCourtney Stairs\, Uppsala University\, Sweden\n\n\n\nAndrew Haines\, London School of Hygiene & Tropical Medicine\, Centre on  Climate Change and Planetary Health\, UK\n\n\n\nArnau Sebé-Pedrós\, Centre for Genomic Regulation\, Spain & Wellcome Sanger Institute\, UK\n\n\n\nColin Averill\, Funga Public Benefit Corporation\, US\n\n\n\nAnne E. Magurran\, University of St Andrews\, Scotland\n\n\n\nJenni Lehtimäki\, Finnish Environment Institute\, Finland\n\n\n\nFederico Ariel\, IFIBYNE-CONICET\, Argentina\n\n\n\nAnna-Liisa Laine\, University of Helsinki\, Finland\n\n\n\n\nRegister and submit your abstract on the event website \n\n\n\nFor further questions\, reach out to Scientific Coordinator Anabella Aguilera (anabella.aguilera@scilifelab.se) \n\n\n\nEvent website\n\n\n\nPowered By EmbedPress URL:https://www.scilifelab.se/event/integrating-scales-in-planetary-biology/ LOCATION:Lecture Hall X\, University Main Building\, Uppsala\, Biskopsgatan 3\, Uppsala\, 75105\, Sweden CATEGORIES:Event ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2024/01/PB-conference_-PBwebsite_deadlines_crop2.png ORGANIZER;CN="SciLifeLab Planetary Biology Strategic Area":MAILTO:anabella.aguilera@scilifelab.se END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20261029T120000 DTEND;TZID=Europe/Stockholm:20261029T130000 DTSTAMP:20260819T123224Z CREATED:20260819T121702Z LAST-MODIFIED:20260819T123224Z UID:10001869-1793275200-1793278800@www.scilifelab.se SUMMARY:Campus Solna Seminar Series: Konstantinos Antonopoulos & Ankit Gupta DESCRIPTION:Welcome to join the Campus Solna Seminar Series – an initiative to promote the fantastic science ongoing at Campus Solna and hopefully forge more internal communication and collaboration between within Campus Solna. The format consists of two 20 min talks (One speaker from the Alpha-building and one from the Gamma-building respectively)\, with an additional 5 min of questions. Presentation of ongoing (unpublished) projects is strongly encouraged. \n\n\n\nThe seminars are held Thursdays 12:00-13:00. You can bring your lunch to the seminar. \n\n\n\nPhD students that are attending the Campus Solna Seminar lectures will have the opportunity to gain credits. For the syllabus and instructions on how to obtain these credits\, read this document. Please contact your own department at your host University to confirm.See here the full schedule for this semester. \n\n\n\nThis week:\n\n\n\n\n\n\nKonstantinos Antonopoulos\n\n\n\nFredrik Edfors – gamma \n\n\n\n \n\n\n\n\n\nAnkit Gupta\n\n\n\nEmma Lundberg – alpha \n\n\n\n \n\n\n\n\n\n\nThis seminar series is organized by the PhD & Postdoc Council. For more information about the Council and other events check our page. URL:https://www.scilifelab.se/event/campus-solna-seminar-series-29oct/ LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden CATEGORIES:Community ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2022/09/IMG_20221103_120135408_HDR-scaled.jpg ORGANIZER;CN="SciLifeLab Solna PhD & Postdoc Council":MAILTO:phd-council@scilifelab.se END:VEVENT END:VCALENDAR